| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP11A TBC1D3C TBC1D3B RGS6 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 3.25e-08 | 279 | 129 | 13 | GO:0005096 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP11A TBC1D3C TBC1D3B RGS6 PLCG1 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 5.23e-06 | 507 | 129 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP11A TBC1D3C TBC1D3B RGS6 PLCG1 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 5.23e-06 | 507 | 129 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF18A HYOU1 ATP8A2 KIF21A CFTR CHD8 KIF20B NPM2 BPTF DDX50 SHPRH HLTF DNAH6 HSPA9 | 4.40e-05 | 614 | 129 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | phosphopyruvate hydratase activity | 2.46e-04 | 4 | 129 | 2 | GO:0004634 | |
| GeneOntologyMolecularFunction | enzyme activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP11A TBC1D3C TBC1D3B RGS6 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 3.30e-04 | 656 | 129 | 13 | GO:0008047 |
| GeneOntologyMolecularFunction | mRNA 5'-UTR binding | 5.46e-04 | 25 | 129 | 3 | GO:0048027 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 6.02e-11 | 109 | 125 | 11 | GO:0090630 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP11A TBC1D3C TBC1D3B RGS6 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 3.06e-09 | 244 | 125 | 13 | GO:0043547 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP11A TBC1D3C TBC1D3B RGS6 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.30e-07 | 335 | 125 | 13 | GO:0043087 |
| GeneOntologyBiologicalProcess | chromatin organization | CENPW LIN54 NSD1 CHD8 ZDBF2 H3-4 NPM2 HP1BP3 BPTF RIF1 ARID1B BRCA1 SUPT6H TET1 SHPRH HLTF PWWP3A PHF14 | 7.68e-06 | 896 | 125 | 18 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromatin remodeling | CENPW LIN54 NSD1 CHD8 ZDBF2 H3-4 NPM2 HP1BP3 BPTF RIF1 ARID1B BRCA1 SUPT6H TET1 SHPRH HLTF | 1.06e-05 | 741 | 125 | 16 | GO:0006338 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP11A TBC1D3C TBC1D3B RGS6 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.08e-05 | 499 | 125 | 13 | GO:0051345 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | CENPW LIN54 NSD1 CHD8 ZDBF2 H3-4 NPM2 HP1BP3 BPTF RIF1 ARID1B BRCA1 SUPT6H TET1 SHPRH HLTF PWWP3A PHF14 | 3.29e-05 | 999 | 125 | 18 | GO:0071824 |
| GeneOntologyBiologicalProcess | DNA repair | GCNA ZCWPW1 POLE REV3L PALB2 RIF1 ARID1B BRCA1 CSNK2A2 SHPRH HLTF PWWP3A USP1 | 1.57e-04 | 648 | 125 | 13 | GO:0006281 |
| Domain | TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 8.25e-13 | 49 | 125 | 10 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.91e-12 | 53 | 125 | 10 | PF00566 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.84e-12 | 55 | 125 | 10 | IPR000195 |
| Domain | TBC_RABGAP | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.84e-12 | 55 | 125 | 10 | PS50086 |
| Domain | Enolase_N | 1.33e-04 | 3 | 125 | 2 | PF03952 | |
| Domain | Enolase | 1.33e-04 | 3 | 125 | 2 | IPR000941 | |
| Domain | Enolase_C | 1.33e-04 | 3 | 125 | 2 | IPR020810 | |
| Domain | Enolase_N | 1.33e-04 | 3 | 125 | 2 | IPR020811 | |
| Domain | Enolase_CS | 1.33e-04 | 3 | 125 | 2 | IPR020809 | |
| Domain | Enolase_C | 1.33e-04 | 3 | 125 | 2 | PF00113 | |
| Domain | Enolase_N | 1.33e-04 | 3 | 125 | 2 | SM01193 | |
| Domain | Enolase_C | 1.33e-04 | 3 | 125 | 2 | SM01192 | |
| Domain | ENOLASE | 1.33e-04 | 3 | 125 | 2 | PS00164 | |
| Domain | - | 2.64e-04 | 4 | 125 | 2 | 3.30.390.10 | |
| Domain | - | 2.64e-04 | 4 | 125 | 2 | 3.20.20.120 | |
| Domain | DNA_pol_B | 2.64e-04 | 4 | 125 | 2 | PF00136 | |
| Domain | Enolase_C-like | 2.64e-04 | 4 | 125 | 2 | IPR029065 | |
| Domain | DNA-dir_DNA_pol_B | 2.64e-04 | 4 | 125 | 2 | IPR006172 | |
| Domain | Enolase_N-like | 2.64e-04 | 4 | 125 | 2 | IPR029017 | |
| Domain | DNA-dir_DNA_pol_B_exonuc | 2.64e-04 | 4 | 125 | 2 | IPR006133 | |
| Domain | DNA-dir_DNA_pol_B_multi_dom | 2.64e-04 | 4 | 125 | 2 | IPR006134 | |
| Domain | DNA_pol_B_exo1 | 2.64e-04 | 4 | 125 | 2 | PF03104 | |
| Domain | POLBc | 2.64e-04 | 4 | 125 | 2 | SM00486 | |
| Domain | PHD | 3.28e-04 | 89 | 125 | 5 | SM00249 | |
| Domain | Znf_PHD | 3.64e-04 | 91 | 125 | 5 | IPR001965 | |
| Domain | ZF_PHD_2 | 4.44e-04 | 95 | 125 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 4.66e-04 | 96 | 125 | 5 | PS01359 | |
| Domain | PWWP | 4.70e-04 | 23 | 125 | 3 | PF00855 | |
| Domain | PWWP_dom | 4.70e-04 | 23 | 125 | 3 | IPR000313 | |
| Domain | PWWP | 5.34e-04 | 24 | 125 | 3 | PS50812 | |
| Domain | Zinc_finger_PHD-type_CS | 9.44e-04 | 65 | 125 | 4 | IPR019786 | |
| Domain | RNaseH-like_dom | 1.18e-03 | 69 | 125 | 4 | IPR012337 | |
| Domain | SNF2_N | 1.26e-03 | 32 | 125 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.26e-03 | 32 | 125 | 3 | PF00176 | |
| Domain | Nucleotide-bd_a/b_plait | 1.77e-03 | 258 | 125 | 7 | IPR012677 | |
| Domain | KH_1 | 2.08e-03 | 38 | 125 | 3 | PF00013 | |
| Domain | - | 2.24e-03 | 39 | 125 | 3 | 3.30.1370.10 | |
| Domain | KH | 2.41e-03 | 40 | 125 | 3 | SM00322 | |
| Domain | KH_dom | 2.41e-03 | 40 | 125 | 3 | IPR004087 | |
| Domain | Kinesin_motor_CS | 2.59e-03 | 41 | 125 | 3 | IPR019821 | |
| Domain | KH_TYPE_1 | 2.78e-03 | 42 | 125 | 3 | PS50084 | |
| Domain | RRM_1 | 2.78e-03 | 208 | 125 | 6 | PF00076 | |
| Domain | - | 2.81e-03 | 12 | 125 | 2 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 2.81e-03 | 12 | 125 | 2 | IPR029047 | |
| Domain | Kinesin-like_fam | 2.97e-03 | 43 | 125 | 3 | IPR027640 | |
| Domain | Znf_FYVE_PHD | 3.11e-03 | 147 | 125 | 5 | IPR011011 | |
| Domain | - | 3.17e-03 | 44 | 125 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 3.17e-03 | 44 | 125 | 3 | PF00225 | |
| Domain | KH_dom_type_1 | 3.17e-03 | 44 | 125 | 3 | IPR004088 | |
| Domain | KISc | 3.17e-03 | 44 | 125 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 3.17e-03 | 44 | 125 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 3.17e-03 | 44 | 125 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 3.17e-03 | 44 | 125 | 3 | PS50067 | |
| Domain | H15 | 3.30e-03 | 13 | 125 | 2 | SM00526 | |
| Domain | - | 3.30e-03 | 13 | 125 | 2 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 3.30e-03 | 13 | 125 | 2 | IPR018181 | |
| Domain | HSP70_C | 3.30e-03 | 13 | 125 | 2 | IPR029048 | |
| Domain | Linker_histone | 3.30e-03 | 13 | 125 | 2 | PF00538 | |
| Domain | H15 | 3.30e-03 | 13 | 125 | 2 | PS51504 | |
| Domain | RRM | 3.42e-03 | 217 | 125 | 6 | SM00360 | |
| Domain | Histone_H1/H5_H15 | 3.84e-03 | 14 | 125 | 2 | IPR005818 | |
| Domain | RRM_dom | 4.26e-03 | 227 | 125 | 6 | IPR000504 | |
| Domain | EF-hand_like | 4.41e-03 | 15 | 125 | 2 | PF09279 | |
| Domain | PI-PLC-Y | 4.41e-03 | 15 | 125 | 2 | PF00387 | |
| Domain | PLCYc | 4.41e-03 | 15 | 125 | 2 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 4.41e-03 | 15 | 125 | 2 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 4.41e-03 | 15 | 125 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 4.41e-03 | 15 | 125 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 4.41e-03 | 15 | 125 | 2 | IPR015359 | |
| Domain | RRM | 4.54e-03 | 230 | 125 | 6 | PS50102 | |
| Domain | HSP70 | 5.01e-03 | 16 | 125 | 2 | PF00012 | |
| Domain | HSP70_2 | 5.66e-03 | 17 | 125 | 2 | PS00329 | |
| Domain | HSP70_1 | 5.66e-03 | 17 | 125 | 2 | PS00297 | |
| Domain | HSP70_3 | 5.66e-03 | 17 | 125 | 2 | PS01036 | |
| Domain | Helicase_C | 5.81e-03 | 107 | 125 | 4 | PF00271 | |
| Domain | HELICc | 5.81e-03 | 107 | 125 | 4 | SM00490 | |
| Domain | Helicase_C | 6.00e-03 | 108 | 125 | 4 | IPR001650 | |
| Domain | - | 6.03e-03 | 244 | 125 | 6 | 3.30.70.330 | |
| Domain | HELICASE_CTER | 6.20e-03 | 109 | 125 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 6.20e-03 | 109 | 125 | 4 | PS51192 | |
| Domain | DEXDc | 6.20e-03 | 109 | 125 | 4 | SM00487 | |
| Domain | PI-PLC-X | 6.34e-03 | 18 | 125 | 2 | PF00388 | |
| Domain | PLCXc | 6.34e-03 | 18 | 125 | 2 | SM00148 | |
| Domain | Hsp_70_fam | 6.34e-03 | 18 | 125 | 2 | IPR013126 | |
| Domain | Helicase_ATP-bd | 6.40e-03 | 110 | 125 | 4 | IPR014001 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K | 1.54e-08 | 99 | 92 | 9 | M46448 |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.29e-27 | 11 | 130 | 11 | 16863688 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | HIVEP1 TCF20 LIN54 RPS7 UTP14A NSD1 CHD8 NOL10 ZDBF2 RBM28 H3-4 KIF20B HP1BP3 BPTF NIFK RIF1 IGF2BP1 ARID1B BBX DDX50 BRCA1 CEBPZ RBM19 PHF14 ENO1 PHIP RSBN1L | 1.94e-16 | 954 | 130 | 27 | 36373674 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | KIF18A ESS2 TCF20 RPS7 UTP14A NOL10 RBM28 ARHGAP11A KIF20B BPTF NIFK RIF1 DDX50 CEBPZ SUPT6H RBM19 CSNK2A2 HLTF PWWP3A PHF14 HADHB ZBTB11 ENO1 HSPA9 RSBN1L | 3.73e-14 | 989 | 130 | 25 | 36424410 |
| Pubmed | HYOU1 TCF20 POLE RPS7 UTP14A NSD1 CHD8 NOL10 RBM28 HP1BP3 BPTF NIFK RIF1 IGF2BP2 FXR1 CEBPZ SUPT6H CSNK2A2 ZBTB11 PHIP HSPA9 | 5.27e-14 | 653 | 130 | 21 | 22586326 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | HIVEP1 ESS2 TCF20 CTDSPL2 LIN54 NSD1 CHD8 ARHGAP11A KIF20B HP1BP3 BPTF RIF1 BBX BRCA1 CSNK2A2 SHPRH HLTF PHF14 ZBTB11 PHIP | 1.46e-13 | 608 | 130 | 20 | 36089195 |
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | TCF20 LIN54 UTP14A NSD1 CHD8 KIF20B RIF1 IGF2BP2 BBX RBM19 PHIP | 3.64e-13 | 109 | 130 | 11 | 33554859 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ESS2 HYOU1 LIN54 RPS7 UTP14A PRPF38B CHD8 NOL10 RBM28 CDKAL1 HP1BP3 NIFK PPIG IGF2BP1 IGF2BP2 FXR1 CCDC71 DDX50 CEBPZ CSNK2A2 HLTF HADHB ENO1 PHIP HSPA9 RSBN1L | 3.08e-12 | 1318 | 130 | 26 | 30463901 |
| Pubmed | HYOU1 CTDSPL2 KIF21A LIN54 RPS7 UTP14A H3-4 PALB2 HP1BP3 BPTF USP8 FXR1 BBX DDX50 BRCA1 DOK4 SUGCT CEBPZ ASPM PHF14 HADHB DTHD1 ZBTB11 USP1 ENO1 DNAH6 HSPA9 | 3.66e-12 | 1442 | 130 | 27 | 35575683 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | TCF20 TMEM237 CTDSPL2 LIN54 RPS7 NSD1 NOL10 RBM28 ARHGAP11A PALB2 CDKAL1 HP1BP3 BPTF NIFK RIF1 PPIG BBX DDX50 BRCA1 CEBPZ SUPT6H HLTF PHF14 HADHB HSPA9 | 1.34e-11 | 1294 | 130 | 25 | 30804502 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | KIF18A POLE RPS7 UTP14A NOL10 RBM28 KIF20B HP1BP3 BPTF NIFK RIF1 IGF2BP1 IGF2BP2 FXR1 DDX50 CEBPZ DROSHA ASPM ZBTB11 | 6.90e-11 | 759 | 130 | 19 | 35915203 |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | TCF20 UTP14A NOL10 RBM28 HP1BP3 NIFK IGF2BP1 DDX50 CEBPZ RBM19 CSNK2A2 PHF14 PHIP | 7.63e-10 | 349 | 130 | 13 | 25665578 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TCF20 POLE KIF21A RPS7 UTP14A CHD8 NOL10 RBM28 KIF20B NIFK RIF1 IGF2BP2 FXR1 DDX50 CEBPZ RBM19 ASPM HLTF PLCG1 HADHB ENO1 PHIP HSPA9 | 1.17e-09 | 1353 | 130 | 23 | 29467282 |
| Pubmed | TMEM237 COBLL1 PRPF38B NOL10 RBM28 HP1BP3 CEP350 NIFK RIF1 PPIG IGF2BP1 IGF2BP2 FXR1 CEBPZ DROSHA RBM19 CSNK2A2 RPS19BP1 HADHB HAL ENO1 HSPA9 RSBN1L | 1.51e-09 | 1371 | 130 | 23 | 36244648 | |
| Pubmed | RPS7 UTP14A NOL10 RBM28 HP1BP3 CEP350 NIFK RIF1 DDX50 CEBPZ RBM19 RPS19BP1 HADHB RSBN1L | 4.15e-09 | 483 | 130 | 14 | 36912080 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | TCF20 KIF21A RPS7 NOL10 RBM28 NIFK PPIG FXR1 DDX50 CEBPZ PHF14 PHIP | 4.63e-09 | 330 | 130 | 12 | 33301849 |
| Pubmed | 8.08e-09 | 156 | 130 | 9 | 37108203 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | RPS7 UTP14A NOL10 RBM28 HP1BP3 NIFK IGF2BP1 IGF2BP2 DDX50 CEBPZ SUPT6H RBM19 PHF14 ENO1 HSPA9 | 9.14e-09 | 605 | 130 | 15 | 28977666 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HYOU1 TCF20 UTP14A RBM28 HP1BP3 CEP350 BPTF NIFK RIF1 IGF2BP1 IGF2BP2 FXR1 DDX50 CEBPZ SUPT6H HADHB ENO1 PHIP HSPA9 | 9.56e-09 | 1024 | 130 | 19 | 24711643 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | MRPL21 RPS7 UTP14A NOL10 RBM28 NIFK PPIG IGF2BP1 IGF2BP2 FXR1 DDX50 CEBPZ SUPT6H DROSHA RBM19 RPS19BP1 HSPA9 | 9.81e-09 | 807 | 130 | 17 | 22681889 |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 1.27e-08 | 74 | 130 | 7 | 16625196 | |
| Pubmed | 1.39e-08 | 116 | 130 | 8 | 21282530 | ||
| Pubmed | MRPL21 HIVEP1 ESS2 TCF20 LIN54 UTP14A CHD8 RBM28 HP1BP3 BPTF NIFK RIF1 IGF2BP1 ARID1B IGF2BP2 BBX DDX50 BRCA1 CSNK2A2 ZMYM1 HADHB HAL | 1.68e-08 | 1429 | 130 | 22 | 35140242 | |
| Pubmed | HIVEP1 ESS2 HYOU1 TCF20 LIN54 PRPF38B CHD8 RBM28 PALB2 BPTF NIFK IGF2BP1 ARID1B IGF2BP2 BRCA1 CSNK2A2 HLTF HADHB HSPA9 | 3.11e-08 | 1103 | 130 | 19 | 34189442 | |
| Pubmed | 3.85e-08 | 250 | 130 | 10 | 33536335 | ||
| Pubmed | UTP14A NOL10 RBM28 HP1BP3 NIFK FXR1 CEBPZ RBM19 CSNK2A2 PHF14 PHIP | 5.38e-08 | 332 | 130 | 11 | 25693804 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HIVEP1 HYOU1 POLE RPS7 UTP14A NOL10 MAST2 NIFK RIF1 IGF2BP1 FXR1 DDX50 CEBPZ SUPT6H RBM19 CSNK2A2 PLCG1 HADHB ENO1 PHIP HSPA9 | 7.75e-08 | 1425 | 130 | 21 | 30948266 |
| Pubmed | KIF18A HYOU1 CTDSPL2 RPS7 NOL10 C2CD4C CEP350 NIFK RIF1 ARID1B IGF2BP2 DDX50 CEBPZ TTI1 HADHB MAPK11 USP1 PLK4 | 7.87e-08 | 1049 | 130 | 18 | 27880917 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | CTDSPL2 UTP14A NSD1 CHD8 NOL10 HP1BP3 BPTF NIFK RIF1 BBX CSNK2A2 ZBTB11 PHIP | 1.14e-07 | 533 | 130 | 13 | 30554943 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | UTP14A CHD8 NOL10 RBM28 KIF20B BPTF RIF1 PPIG CEBPZ RBM19 RPS19BP1 | 1.60e-07 | 370 | 130 | 11 | 22922362 |
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 2.04e-07 | 4 | 130 | 3 | 12359748 | |
| Pubmed | 2.04e-07 | 4 | 130 | 3 | 8406013 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | HYOU1 RPS7 UTP14A NOL10 RBM28 ARHGAP11A KIF20B HP1BP3 NIFK IGF2BP2 FXR1 DDX50 CEBPZ RBM19 CSNK2A2 HADHB ENO1 HSPA9 RSBN1L | 2.35e-07 | 1257 | 130 | 19 | 36526897 |
| Pubmed | 2.88e-07 | 116 | 130 | 7 | 30804394 | ||
| Pubmed | TCF20 RPS7 PRPF38B KIF20B CC2D2B BPTF ARID1B HLTF TTI1 HAL HSPA9 | 3.14e-07 | 396 | 130 | 11 | 26687479 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | CTDSPL2 RPS7 CHD8 KIF20B BPTF PPIG IGF2BP2 CSNK2A2 RPS19BP1 PKNOX1 HSPA9 | 4.54e-07 | 411 | 130 | 11 | 35182466 |
| Pubmed | MRPL21 RPS7 PRPF38B RBM28 HP1BP3 NIFK PPIG IGF2BP1 IGF2BP2 FXR1 BBX DDX50 CSNK2A2 RSBN1L | 5.00e-07 | 713 | 130 | 14 | 29802200 | |
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 12604796 | ||
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 8471161 | ||
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 31376680 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | HYOU1 RPS7 UTP14A H3-4 HP1BP3 NIFK IGF2BP1 IGF2BP2 FXR1 DDX50 DROSHA HADHB ENO1 HSPA9 | 5.09e-07 | 714 | 130 | 14 | 28302793 |
| Pubmed | ESS2 HYOU1 TCF20 ZDBF2 RBM28 CDKAL1 CEP350 USP8 ARID1B FXR1 CEBPZ ZMYM1 USP1 RSBN1L | 6.94e-07 | 733 | 130 | 14 | 34672954 | |
| Pubmed | UTP14A NSD1 PRPF38B CHD8 NOL10 KIF20B NIFK RIF1 BBX DDX50 BRCA1 CEBPZ SUPT6H DROSHA RBM19 CSNK2A2 HLTF PHF14 ZBTB11 RSBN1L | 7.66e-07 | 1497 | 130 | 20 | 31527615 | |
| Pubmed | HYOU1 RBM28 PALB2 HP1BP3 ARID1B FXR1 DDX50 BRCA1 CCNE2 CSNK2A2 ZMYM1 HADHB ENO1 | 8.10e-07 | 634 | 130 | 13 | 34591612 | |
| Pubmed | KIF18A TRAPPC11 ZCWPW1 TBC1D3 TBC1D3D QRICH2 KIF20B BBX TC2N RBM19 NRK USP1 ENO1 TBC1D3F | 9.10e-07 | 750 | 130 | 14 | 11230166 | |
| Pubmed | CHD8 REV3L MAST2 CDKAL1 BPTF NIFK ARID1B IGF2BP2 FXR1 TC2N BRCA1 DROSHA CSNK2A2 ASPM PHIP RSBN1L SEZ6L | 9.70e-07 | 1116 | 130 | 17 | 31753913 | |
| Pubmed | 1.21e-06 | 281 | 130 | 9 | 26725010 | ||
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | RBM28 HP1BP3 NIFK FXR1 DDX50 CEBPZ DROSHA CSNK2A2 ASPM ZBTB11 | 1.22e-06 | 364 | 130 | 10 | 24778252 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.28e-06 | 283 | 130 | 9 | 30585729 | |
| Pubmed | LIN54 RPS7 UTP14A C2CD4C HP1BP3 CEP350 RIF1 IGF2BP1 BBX DDX50 BRCA1 RBM19 PWWP3A HSPA9 | 1.38e-06 | 777 | 130 | 14 | 35844135 | |
| Pubmed | POLE CHD8 BPTF NIFK FXR1 CEBPZ SUPT6H CSNK2A2 RPS19BP1 PHF14 PHIP | 1.64e-06 | 469 | 130 | 11 | 27634302 | |
| Pubmed | TCF20 RPS7 PRPF38B CHD8 NOL10 CDKAL1 BPTF RIF1 ARID1B ASPM HAL | 1.75e-06 | 472 | 130 | 11 | 38943005 | |
| Pubmed | 1.77e-06 | 7 | 130 | 3 | 34079090 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.48e-06 | 394 | 130 | 10 | 27248496 | |
| Pubmed | 2.61e-06 | 26 | 130 | 4 | 23435420 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | RPS7 UTP14A NOL10 RBM28 H3-4 HP1BP3 NIFK IGF2BP1 FXR1 DDX50 CEBPZ RPS19BP1 HAL ENO1 HSPA9 | 2.84e-06 | 949 | 130 | 15 | 36574265 |
| Pubmed | ZFAT HIVEP1 DZIP1 MAST2 ARID1B SUPT6H DROSHA USP1 ENO1 ENO3 HSPA9 | 2.87e-06 | 497 | 130 | 11 | 23414517 | |
| Pubmed | 2.99e-06 | 234 | 130 | 8 | 36243803 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | TCF20 RPS7 UTP14A PRPF38B HP1BP3 BPTF NIFK PPIG IGF2BP1 ARID1B IGF2BP2 BBX DDX50 SUPT6H DROSHA HADHB | 3.03e-06 | 1082 | 130 | 16 | 38697112 |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 3.17e-06 | 316 | 130 | 9 | 31665637 | |
| Pubmed | 3.34e-06 | 167 | 130 | 7 | 35833506 | ||
| Pubmed | RPS7 RBM28 HP1BP3 NIFK IGF2BP1 ARID1B IGF2BP2 FXR1 DDX50 SUPT6H DROSHA HADHB | 3.64e-06 | 615 | 130 | 12 | 31048545 | |
| Pubmed | RPS7 HP1BP3 CEP350 NIFK IGF2BP2 DDX50 CEBPZ CSNK2A2 SHPRH RSBN1L | 4.09e-06 | 417 | 130 | 10 | 36537216 | |
| Pubmed | 5.08e-06 | 335 | 130 | 9 | 15741177 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | RPS7 UTP14A RBM28 NIFK IGF2BP1 IGF2BP2 DDX50 HADHB ENO1 HSPA9 | 5.36e-06 | 430 | 130 | 10 | 38172120 |
| Pubmed | 5.59e-06 | 339 | 130 | 9 | 30415952 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HYOU1 KIF21A RPS7 UTP14A HP1BP3 NIFK USP8 RIF1 IGF2BP1 FXR1 CEBPZ SUPT6H RBM19 CSNK2A2 HLTF HADHB ENO1 HSPA9 | 5.70e-06 | 1415 | 130 | 18 | 28515276 |
| Pubmed | 5.73e-06 | 340 | 130 | 9 | 29478914 | ||
| Pubmed | 6.01e-06 | 10 | 130 | 3 | 19082521 | ||
| Pubmed | 6.01e-06 | 10 | 130 | 3 | 20509872 | ||
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 6.30e-06 | 259 | 130 | 8 | 30404004 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | CHD8 RBM28 NIFK ARID1B FXR1 DDX50 CEBPZ SUPT6H CSNK2A2 ZBTB11 | 6.55e-06 | 440 | 130 | 10 | 34244565 |
| Pubmed | KIF18A TCF20 POLE NSD1 KIF20B PALB2 RIF1 ARID1B BRCA1 PWWP3A | 8.44e-06 | 453 | 130 | 10 | 29656893 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 9.25e-06 | 361 | 130 | 9 | 30344098 | |
| Pubmed | 1.10e-05 | 12 | 130 | 3 | 28700933 | ||
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 1.18e-05 | 134 | 130 | 6 | 25452129 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MRPL21 ESS2 HYOU1 POLE UTP14A NOL10 ZDBF2 RBM28 C2CD4C CDKAL1 NIFK IGF2BP1 IGF2BP2 FXR1 DDX50 HADHB PHIP HSPA9 | 1.21e-05 | 1496 | 130 | 18 | 32877691 |
| Pubmed | RIF1 counteracts BRCA1-mediated end resection during DNA repair. | 1.39e-05 | 2 | 130 | 2 | 23486525 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 2090519 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 34245638 | ||
| Pubmed | Lifelong restructuring of 3D genome architecture in cerebellar granule cells. | 1.39e-05 | 2 | 130 | 2 | 37676945 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 19726068 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 23504457 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 29739757 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 24636221 | ||
| Pubmed | Genome-wide analysis reveals a role for BRCA1 and PALB2 in transcriptional co-activation. | 1.39e-05 | 2 | 130 | 2 | 24591564 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 35006619 | ||
| Pubmed | A family of IGF-II mRNA binding proteins (IMP) involved in RNA trafficking. | 1.39e-05 | 2 | 130 | 2 | 11713986 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 32192191 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 30289697 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 9169614 | ||
| Pubmed | The abnormal spindle-like, microcephaly-associated (ASPM) gene encodes a centrosomal protein. | 1.39e-05 | 2 | 130 | 2 | 16123590 | |
| Pubmed | BRCA1 regulates microRNA biogenesis via the DROSHA microprocessor complex. | 1.39e-05 | 2 | 130 | 2 | 22492723 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 28867767 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 24058532 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 11229603 | ||
| Pubmed | Common type 2 diabetes risk gene variants associate with gestational diabetes. | 1.42e-05 | 13 | 130 | 3 | 18984664 | |
| Pubmed | 1.55e-05 | 83 | 130 | 5 | 28794006 | ||
| Pubmed | KIF18A ESS2 RPS7 UTP14A PRPF38B IGF2BP1 IGF2BP2 FXR1 DDX50 RBM19 RPS19BP1 HADHB | 1.83e-05 | 723 | 130 | 12 | 34133714 | |
| Pubmed | RPS7 NOL10 RBM28 HP1BP3 NIFK RIF1 IGF2BP2 FXR1 DDX50 CEBPZ DROSHA CSNK2A2 HADHB | 1.85e-05 | 847 | 130 | 13 | 35850772 | |
| Pubmed | 1.85e-05 | 86 | 130 | 5 | 37253089 | ||
| Interaction | ZNF330 interactions | ESS2 TCF20 POLE UTP14A NSD1 NOL10 RBM28 HP1BP3 NIFK BBX DDX50 CEBPZ SUPT6H RBM19 SHPRH HLTF RSPO2 PHF14 ZBTB11 PHIP RSBN1L | 4.74e-13 | 446 | 125 | 21 | int:ZNF330 |
| Interaction | H2BC8 interactions | KIF18A ESS2 TCF20 CTDSPL2 LIN54 UTP14A NSD1 CHD8 ARHGAP11A H3-4 KIF20B PALB2 HP1BP3 BPTF NIFK RIF1 BBX BRCA1 CSNK2A2 PHF14 ENO1 PHIP | 7.90e-12 | 576 | 125 | 22 | int:H2BC8 |
| Interaction | SMC5 interactions | HIVEP1 TCF20 LIN54 RPS7 UTP14A NSD1 CHD8 NOL10 ZDBF2 RBM28 REV3L H3-4 KIF20B HP1BP3 BPTF NIFK RIF1 IGF2BP1 ARID1B BBX DDX50 BRCA1 CEBPZ RBM19 PHF14 ENO1 PHIP RSBN1L | 1.31e-11 | 1000 | 125 | 28 | int:SMC5 |
| Interaction | POLR1G interactions | TCF20 LIN54 UTP14A NSD1 CHD8 NOL10 RBM28 KIF20B BPTF NIFK BBX DDX50 CEBPZ SUPT6H RBM19 CSNK2A2 PHF14 ZBTB11 PHIP RSBN1L | 2.31e-11 | 489 | 125 | 20 | int:POLR1G |
| Interaction | H3C3 interactions | HIVEP1 ESS2 TCF20 CTDSPL2 LIN54 NSD1 CHD8 ARHGAP11A KIF20B HP1BP3 BPTF RIF1 BBX BRCA1 SUPT6H CSNK2A2 SHPRH HLTF PHF14 PHIP | 2.88e-11 | 495 | 125 | 20 | int:H3C3 |
| Interaction | NPM1 interactions | PLCZ1 MRPL21 HIVEP1 CENPW CFTR RPS7 UTP14A NSD1 CHD8 NOL10 DZIP1 RBM28 H3-4 NPM2 HP1BP3 IGSF10 NIFK IGF2BP2 FXR1 DDX50 BRCA1 CEBPZ RBM19 CSNK2A2 ASPM PLCG1 ZBTB11 ENO1 HSPA9 RSBN1L | 3.59e-11 | 1201 | 125 | 30 | int:NPM1 |
| Interaction | NUP43 interactions | HIVEP1 TCF20 LIN54 NSD1 CHD8 NOL10 ZDBF2 RBM28 HP1BP3 BPTF NIFK RIF1 ARID1B BBX BRCA1 CEBPZ SUPT6H RBM19 HLTF ZMYM1 ZBTB11 PHIP | 3.85e-11 | 625 | 125 | 22 | int:NUP43 |
| Interaction | H3-3A interactions | HIVEP1 ESS2 TCF20 CTDSPL2 LIN54 NSD1 CHD8 ARHGAP11A H3-4 KIF20B HP1BP3 BPTF RIF1 BBX CCDC71 BRCA1 CSNK2A2 SHPRH HLTF PHF14 HADHB ZBTB11 PHIP | 1.97e-10 | 749 | 125 | 23 | int:H3-3A |
| Interaction | MAGEB2 interactions | CFTR NSD1 NOL10 RBM28 HP1BP3 NIFK PPIG BBX DDX50 BRCA1 CEBPZ DROSHA RBM19 ZBTB11 RSBN1L | 4.53e-09 | 349 | 125 | 15 | int:MAGEB2 |
| Interaction | POLR1E interactions | HIVEP1 LIN54 UTP14A NSD1 CHD8 NOL10 ZDBF2 RBM28 NIFK BBX CEBPZ RBM19 CSNK2A2 TET1 ZBTB11 | 4.71e-09 | 350 | 125 | 15 | int:POLR1E |
| Interaction | SIRT7 interactions | HYOU1 TCF20 POLE RPS7 UTP14A NSD1 CHD8 NOL10 RBM28 HP1BP3 BPTF NIFK RIF1 IGF2BP2 FXR1 CEBPZ SUPT6H CSNK2A2 ZBTB11 PHIP HSPA9 | 5.94e-09 | 744 | 125 | 21 | int:SIRT7 |
| Interaction | TWIST1 interactions | TCF20 LIN54 UTP14A NSD1 CHD8 KIF20B RIF1 IGF2BP2 BBX RBM19 PHIP | 8.99e-09 | 170 | 125 | 11 | int:TWIST1 |
| Interaction | ADARB1 interactions | TCF20 RPS7 CHD8 NOL10 RBM28 TCEANC HP1BP3 BPTF NIFK BBX DDX50 CEBPZ RBM19 PHF14 ZBTB11 HSPA9 RSBN1L | 9.52e-09 | 489 | 125 | 17 | int:ADARB1 |
| Interaction | H2BC21 interactions | TCF20 CTDSPL2 NSD1 CHD8 H3-4 PALB2 HP1BP3 BPTF USP8 RIF1 ARID1B RGS6 CCDC71 BRCA1 SUPT6H TET1 SHPRH HLTF PHF14 PHIP | 1.06e-08 | 696 | 125 | 20 | int:H2BC21 |
| Interaction | IFI16 interactions | UTP14A NOL10 RBM28 HP1BP3 NIFK IGF2BP1 IGF2BP2 FXR1 DDX50 BRCA1 CEBPZ RBM19 CSNK2A2 ASPM PHF14 DTHD1 ENO1 PHIP HSPA9 RSBN1L | 1.62e-08 | 714 | 125 | 20 | int:IFI16 |
| Interaction | PARP1 interactions | HIVEP1 HYOU1 CTDSPL2 POLE CFTR UTP14A NSD1 NOL10 RBM28 H3-4 HP1BP3 BPTF IGF2BP1 BBX DDX50 BRCA1 CEBPZ SUPT6H RBM19 CSNK2A2 SHPRH HLTF PKNOX1 PHF14 USP1 PHIP RSBN1L | 2.82e-08 | 1316 | 125 | 27 | int:PARP1 |
| Interaction | ASF1A interactions | HIVEP1 ESS2 TCF20 LIN54 NSD1 CHD8 H3-4 KIF20B RIF1 ARID1B BRCA1 PHF14 | 4.98e-08 | 249 | 125 | 12 | int:ASF1A |
| Interaction | COIL interactions | HIVEP1 ESS2 TCF20 NSD1 CHD8 NOL10 RBM28 NIFK FXR1 BBX CEBPZ SUPT6H CSNK2A2 HLTF ZBTB11 RSBN1L RBM41 | 5.58e-08 | 552 | 125 | 17 | int:COIL |
| Interaction | KIF23 interactions | COBLL1 RPS7 UTP14A NSD1 PRPF38B NOL10 MAST2 KIF20B NIFK USP8 PPIG IGF2BP1 IGF2BP2 FXR1 DDX50 BRCA1 CEBPZ DROSHA CSNK2A2 ASPM HADHB ENO1 PHIP | 8.13e-08 | 1031 | 125 | 23 | int:KIF23 |
| Interaction | CBX3 interactions | ESS2 TCF20 COBLL1 LIN54 UTP14A NSD1 CHD8 H3-4 HP1BP3 RIF1 BBX CCDC71 BRCA1 RPS19BP1 ZMYM1 PHIP HSPA9 RSBN1L | 9.89e-08 | 646 | 125 | 18 | int:CBX3 |
| Interaction | EED interactions | HYOU1 RPS7 UTP14A NSD1 NOL10 RBM28 H3-4 KIF20B HP1BP3 BPTF NIFK RIF1 IGF2BP1 IGF2BP2 FXR1 CCDC71 DDX50 BRCA1 CEBPZ SUPT6H DROSHA RBM19 NRK TTC21B SHPRH ENO1 HSPA9 | 1.90e-07 | 1445 | 125 | 27 | int:EED |
| Interaction | NR2C2 interactions | ESS2 HYOU1 LIN54 RPS7 UTP14A PRPF38B CHD8 NOL10 RBM28 CDKAL1 HP1BP3 NIFK PPIG IGF2BP1 IGF2BP2 FXR1 CCDC71 DDX50 CEBPZ CSNK2A2 HLTF HADHB ENO1 PHIP HSPA9 RSBN1L | 3.94e-07 | 1403 | 125 | 26 | int:NR2C2 |
| Interaction | SNRNP40 interactions | HIVEP1 ESS2 TCF20 NOL10 ZDBF2 RBM28 NIFK ARID1B DDX50 BRCA1 CEBPZ SUPT6H HLTF ZMYM1 ZBTB11 RSBN1L RBM41 | 4.24e-07 | 637 | 125 | 17 | int:SNRNP40 |
| Interaction | SRSF6 interactions | KIF21A PRPF38B NOL10 RBM28 HP1BP3 BPTF NIFK PPIG FXR1 BBX DDX50 CEBPZ RBM19 ZBTB11 RSBN1L | 5.39e-07 | 503 | 125 | 15 | int:SRSF6 |
| Interaction | FGFBP1 interactions | RPS7 UTP14A NOL10 RBM28 HP1BP3 NIFK BBX DDX50 CEBPZ RBM19 RSBN1L | 6.03e-07 | 257 | 125 | 11 | int:FGFBP1 |
| Interaction | CENPA interactions | HIVEP1 TCF20 POLE NSD1 NOL10 HP1BP3 BPTF BBX CEBPZ SHPRH HLTF PHF14 PHIP | 6.47e-07 | 377 | 125 | 13 | int:CENPA |
| Interaction | SMG7 interactions | HIVEP1 ESS2 TCF20 CHD8 ZDBF2 ARID1B IGF2BP2 FXR1 BRCA1 CSNK2A2 TET1 PHIP | 7.18e-07 | 319 | 125 | 12 | int:SMG7 |
| Interaction | H2AX interactions | HYOU1 CHD8 H3-4 PALB2 BPTF ARID1B BRCA1 SUPT6H RBM19 CDADC1 HLTF PHF14 ZBTB11 ENO1 DNAH6 HSPA9 | 8.28e-07 | 593 | 125 | 16 | int:H2AX |
| Interaction | USP36 interactions | RPS7 UTP14A NOL10 RBM28 HP1BP3 CEP350 NIFK RIF1 DDX50 CEBPZ DROSHA RBM19 RPS19BP1 SHPRH HADHB RSBN1L | 9.45e-07 | 599 | 125 | 16 | int:USP36 |
| Interaction | MYCN interactions | MRPL21 ESS2 TCF20 RPS7 UTP14A PRPF38B NOL10 RBM28 HP1BP3 NIFK PPIG IGF2BP1 ARID1B IGF2BP2 FXR1 BBX DDX50 BRCA1 CEBPZ RBM19 CSNK2A2 RPS19BP1 HADHB ENO1 HSPA9 | 9.52e-07 | 1373 | 125 | 25 | int:MYCN |
| Interaction | RNF151 interactions | 9.92e-07 | 123 | 125 | 8 | int:RNF151 | |
| Interaction | CHD3 interactions | RPS7 UTP14A NOL10 RBM28 HP1BP3 BPTF NIFK RIF1 IGF2BP1 IGF2BP2 DDX50 CEBPZ SUPT6H SHPRH PHF14 ENO1 PLK4 HSPA9 | 1.00e-06 | 757 | 125 | 18 | int:CHD3 |
| Interaction | CHD4 interactions | TCF20 RPS7 UTP14A NOL10 RBM28 H3-4 HP1BP3 BPTF NIFK IGF2BP1 DDX50 SUPT6H RBM19 CSNK2A2 RPS19BP1 SHPRH PHF14 ENO1 PHIP HSPA9 | 1.29e-06 | 938 | 125 | 20 | int:CHD4 |
| Interaction | TERF2IP interactions | HIVEP1 ESS2 TCF20 LIN54 UTP14A NSD1 CHD8 KIF20B HP1BP3 BPTF RIF1 BBX BRCA1 SUPT6H ZMYM1 | 1.72e-06 | 552 | 125 | 15 | int:TERF2IP |
| Interaction | RPS6 interactions | MRPL21 CFTR RPS7 UTP14A NOL10 RBM28 HP1BP3 NIFK FXR1 BBX DDX50 BRCA1 CEBPZ RBM19 CSNK2A2 HADHB ZBTB11 PHIP RSBN1L | 1.85e-06 | 874 | 125 | 19 | int:RPS6 |
| Interaction | CEBPA interactions | HIVEP1 ESS2 HYOU1 TCF20 LIN54 PRPF38B CHD8 NOL10 RBM28 PALB2 HP1BP3 BPTF NIFK IGF2BP1 ARID1B IGF2BP2 BRCA1 CEBPZ CSNK2A2 HLTF HADHB GRIN3A HSPA9 | 2.19e-06 | 1245 | 125 | 23 | int:CEBPA |
| Interaction | MNDA interactions | 2.66e-06 | 188 | 125 | 9 | int:MNDA | |
| Interaction | HECTD1 interactions | KIF18A POLE RPS7 UTP14A PRPF38B NOL10 RBM28 KIF20B HP1BP3 BPTF NIFK RIF1 IGF2BP1 IGF2BP2 FXR1 DDX50 CEBPZ DROSHA ASPM ZBTB11 | 2.68e-06 | 984 | 125 | 20 | int:HECTD1 |
| Interaction | DHX40 interactions | ESS2 UTP14A NSD1 NOL10 ZDBF2 RBM28 BRCA1 CEBPZ SUPT6H DROSHA | 3.54e-06 | 249 | 125 | 10 | int:DHX40 |
| Interaction | H2AB2 interactions | 4.65e-06 | 107 | 125 | 7 | int:H2AB2 | |
| Interaction | RPL31 interactions | CFTR RPS7 UTP14A NSD1 NOL10 RBM28 NIFK BBX DDX50 BRCA1 CEBPZ SUPT6H RBM19 ZBTB11 ENO1 RSBN1L | 4.84e-06 | 680 | 125 | 16 | int:RPL31 |
| Interaction | MEN1 interactions | TCF20 CFTR RPS7 CHD8 NOL10 RBM28 H3-4 HP1BP3 BPTF NIFK RIF1 ARID1B IGF2BP2 FXR1 DDX50 CEBPZ DROSHA CSNK2A2 HADHB RSBN1L | 5.24e-06 | 1029 | 125 | 20 | int:MEN1 |
| Interaction | CIT interactions | TCF20 RPS7 UTP14A PRPF38B CHD8 NOL10 RBM28 TCEANC HP1BP3 BPTF NIFK RIF1 IGF2BP1 IGF2BP2 FXR1 DDX50 BRCA1 CEBPZ SUPT6H RBM19 HLTF HADHB PHIP RSBN1L | 8.41e-06 | 1450 | 125 | 24 | int:CIT |
| Interaction | NEIL1 interactions | MRPL21 NOL10 RBM28 HP1BP3 NIFK DDX50 CEBPZ RBM19 CSNK2A2 ZBTB11 | 8.77e-06 | 276 | 125 | 10 | int:NEIL1 |
| Interaction | DDX23 interactions | RPS7 UTP14A NOL10 RBM28 NIFK PPIG DDX50 BRCA1 CEBPZ SUPT6H RBM19 HSPA9 RSBN1L | 9.15e-06 | 480 | 125 | 13 | int:DDX23 |
| Interaction | NANOG interactions | TCF20 PRPF38B KIF20B BPTF RIF1 IGF2BP1 ARID1B FXR1 BRCA1 SUPT6H TET1 HLTF HSPA9 | 9.35e-06 | 481 | 125 | 13 | int:NANOG |
| Interaction | SRPK2 interactions | HIVEP1 PRPF38B NOL10 RBM28 MAST2 NPM2 HP1BP3 NIFK PPIG FXR1 DDX50 CEBPZ SUPT6H DROSHA RBM19 DNAH6 | 9.41e-06 | 717 | 125 | 16 | int:SRPK2 |
| Interaction | RPS19 interactions | KIF21A CFTR RPS7 NOL10 RBM28 HP1BP3 BPTF NIFK DDX50 BRCA1 CEBPZ RBM19 CSNK2A2 RPS19BP1 ZBTB11 | 1.01e-05 | 639 | 125 | 15 | int:RPS19 |
| Interaction | RPS16 interactions | CFTR RPS7 UTP14A RBM28 HP1BP3 NIFK IGF2BP1 FXR1 BBX DDX50 BRCA1 RBM19 CSNK2A2 ZBTB11 USP1 RSBN1L | 1.06e-05 | 724 | 125 | 16 | int:RPS16 |
| Interaction | OBSL1 interactions | TCF20 UTP14A PRPF38B NOL10 RBM28 HP1BP3 NIFK RIF1 IGF2BP1 DDX50 CEBPZ SUPT6H RBM19 MAPK11 ENO1 PHIP HSPA9 RSBN1L | 1.15e-05 | 902 | 125 | 18 | int:OBSL1 |
| Interaction | NOP56 interactions | HYOU1 RPS7 UTP14A NSD1 NOL10 RBM28 NIFK IGF2BP1 FXR1 DDX50 BRCA1 CEBPZ RBM19 ENO1 | 1.23e-05 | 570 | 125 | 14 | int:NOP56 |
| Interaction | BRD3 interactions | CTDSPL2 UTP14A NSD1 CHD8 HP1BP3 BPTF NIFK RIF1 BBX TC2N CSNK2A2 PHIP RSBN1L | 1.24e-05 | 494 | 125 | 13 | int:BRD3 |
| Interaction | TLX1 interactions | 1.37e-05 | 175 | 125 | 8 | int:TLX1 | |
| Interaction | H1-4 interactions | NSD1 NOL10 RBM28 REV3L H3-4 HP1BP3 NIFK IGF2BP1 FXR1 BBX DDX50 CEBPZ RBM19 ZBTB11 RSBN1L | 1.37e-05 | 656 | 125 | 15 | int:H1-4 |
| Interaction | H2AC4 interactions | TCF20 RPS7 CHD8 NOL10 H3-4 HP1BP3 DDX50 BRCA1 SUPT6H RBM19 SHPRH HLTF PHF14 | 1.60e-05 | 506 | 125 | 13 | int:H2AC4 |
| Interaction | H1-1 interactions | RPS7 RBM28 REV3L H3-4 HP1BP3 NIFK DDX50 CCNE2 RBM19 CDADC1 ZBTB11 ENO1 RSBN1L | 1.63e-05 | 507 | 125 | 13 | int:H1-1 |
| Interaction | LARP7 interactions | MRPL21 RPS7 NSD1 CHD8 NOL10 RBM28 HP1BP3 NIFK IGF2BP1 IGF2BP2 DDX50 BRCA1 CEBPZ RBM19 CSNK2A2 HADHB ZBTB11 ENO1 ENO3 HSPA9 | 1.66e-05 | 1113 | 125 | 20 | int:LARP7 |
| Interaction | H2AZ1 interactions | TCF20 NSD1 CHD8 H3-4 HP1BP3 BPTF RIF1 CCDC71 PHF14 PLK4 PHIP | 2.02e-05 | 371 | 125 | 11 | int:H2AZ1 |
| Interaction | SP7 interactions | HIVEP1 ESS2 TCF20 LIN54 RBM28 IGF2BP1 ARID1B BRCA1 CSNK2A2 HAL | 2.02e-05 | 304 | 125 | 10 | int:SP7 |
| Interaction | RIT1 interactions | TRAPPC11 CENPW ESS2 TBC1D3H TBC1D3D POLE RPS7 PRPF38B NOL10 TBC1D3C TBC1D3B USP8 BRCA1 CEBPZ SUPT6H RBM19 TBC1D3G ENO1 PLK4 HSPA9 TBC1D3K | 2.13e-05 | 1230 | 125 | 21 | int:RIT1 |
| Interaction | H2AB3 interactions | 2.25e-05 | 136 | 125 | 7 | int:H2AB3 | |
| Interaction | SLFN11 interactions | UTP14A NSD1 PALB2 BPTF RIF1 DDX50 BRCA1 CEBPZ RBM19 PHIP HSPA9 | 2.29e-05 | 376 | 125 | 11 | int:SLFN11 |
| Interaction | AATF interactions | UTP14A NOL10 RBM28 NIFK IGF2BP1 IGF2BP2 FXR1 DDX50 BRCA1 CEBPZ RBM19 | 2.29e-05 | 376 | 125 | 11 | int:AATF |
| Interaction | ZBTB2 interactions | TCF20 KIF21A RPS7 NOL10 RBM28 NIFK PPIG FXR1 DDX50 CEBPZ PHF14 PHIP | 2.40e-05 | 450 | 125 | 12 | int:ZBTB2 |
| Interaction | TUT4 interactions | 2.79e-05 | 95 | 125 | 6 | int:TUT4 | |
| Interaction | SOX15 interactions | 2.83e-05 | 141 | 125 | 7 | int:SOX15 | |
| Interaction | TLX2 interactions | 2.97e-05 | 142 | 125 | 7 | int:TLX2 | |
| Interaction | SHPRH interactions | 3.15e-05 | 97 | 125 | 6 | int:SHPRH | |
| Interaction | FBXO38 interactions | 3.39e-05 | 145 | 125 | 7 | int:FBXO38 | |
| Interaction | APEX1 interactions | HIVEP1 TCF20 CTDSPL2 LIN54 UTP14A NSD1 NOL10 ARHGAP11A KIF20B HP1BP3 BPTF NIFK RIF1 BBX DDX50 BRCA1 CEBPZ DROSHA ZMYM1 ENO3 RSBN1L | 3.46e-05 | 1271 | 125 | 21 | int:APEX1 |
| Interaction | DCPS interactions | RPS7 UTP14A NOL10 HP1BP3 NIFK SUPT6H RBM19 CSNK2A2 HADHB ENO1 PHIP | 3.51e-05 | 394 | 125 | 11 | int:DCPS |
| Interaction | H3C1 interactions | PLCZ1 CENPW COBLL1 NSD1 CHD8 RBM28 ARHGAP11A H3-4 KIF20B PALB2 HP1BP3 BPTF RIF1 BBX SHPRH PHIP RSBN1L | 4.18e-05 | 901 | 125 | 17 | int:H3C1 |
| Interaction | NOP2 interactions | RPS7 UTP14A RBM28 H3-4 HP1BP3 NIFK FXR1 BBX BRCA1 CEBPZ CSNK2A2 | 5.73e-05 | 416 | 125 | 11 | int:NOP2 |
| Interaction | XRCC6 interactions | HYOU1 TCF20 LIN54 UTP14A NSD1 CHD8 BPTF NIFK RIF1 IGF2BP1 BBX DDX50 BRCA1 HAL ENO1 HSPA9 RSBN1L | 6.02e-05 | 928 | 125 | 17 | int:XRCC6 |
| Interaction | LIN28A interactions | MRPL21 NOL10 RBM28 HP1BP3 NIFK IGF2BP1 DDX50 CEBPZ RBM19 ZBTB11 RSBN1L | 6.37e-05 | 421 | 125 | 11 | int:LIN28A |
| Interaction | OASL interactions | 7.69e-05 | 223 | 125 | 8 | int:OASL | |
| Interaction | NIFK interactions | UTP14A NSD1 NOL10 RBM28 NIFK BBX DDX50 CEBPZ RBM19 CSNK2A2 ZBTB11 | 7.86e-05 | 431 | 125 | 11 | int:NIFK |
| Interaction | RPL13A interactions | MRPL21 CFTR RPS7 NOL10 RBM28 HP1BP3 NIFK BBX DDX50 CEBPZ RBM19 ZBTB11 RSBN1L | 7.90e-05 | 591 | 125 | 13 | int:RPL13A |
| Interaction | KAT6A interactions | RPS7 H3-4 HP1BP3 CEP350 NIFK IGF2BP2 DDX50 CEBPZ CSNK2A2 SHPRH PHF14 RSBN1L | 8.01e-05 | 510 | 125 | 12 | int:KAT6A |
| Interaction | FOXP3 interactions | UTP14A CHD8 NOL10 RBM28 KIF20B BPTF RIF1 PPIG CEBPZ RBM19 RPS19BP1 | 8.02e-05 | 432 | 125 | 11 | int:FOXP3 |
| Interaction | RANBP9 interactions | RBM28 HP1BP3 NIFK FXR1 DDX50 BRCA1 CEBPZ PHF14 HADHB ENO1 HSPA9 | 8.19e-05 | 433 | 125 | 11 | int:RANBP9 |
| Interaction | NFAT5 interactions | 8.84e-05 | 38 | 125 | 4 | int:NFAT5 | |
| Interaction | FGF13 interactions | 9.00e-05 | 117 | 125 | 6 | int:FGF13 | |
| Interaction | UTP4 interactions | 9.29e-05 | 170 | 125 | 7 | int:UTP4 | |
| Interaction | H2AC17 interactions | 1.01e-04 | 232 | 125 | 8 | int:H2AC17 | |
| Interaction | PRC1 interactions | CTDSPL2 ATP8A2 RPS7 PRPF38B NOL10 RBM28 HP1BP3 NIFK IGF2BP1 IGF2BP2 FXR1 DDX50 BRCA1 CEBPZ HLTF PHF14 PHIP | 1.07e-04 | 973 | 125 | 17 | int:PRC1 |
| Interaction | ZCCHC10 interactions | 1.14e-04 | 236 | 125 | 8 | int:ZCCHC10 | |
| Interaction | MECP2 interactions | TCF20 RPS7 UTP14A NSD1 PRPF38B RBM28 HP1BP3 BPTF NIFK PPIG IGF2BP1 ARID1B IGF2BP2 BBX DDX50 CEBPZ SUPT6H DROSHA PHF14 HADHB | 1.26e-04 | 1287 | 125 | 20 | int:MECP2 |
| Interaction | H1-7 interactions | 1.28e-04 | 179 | 125 | 7 | int:H1-7 | |
| Interaction | ELOA interactions | 1.35e-04 | 242 | 125 | 8 | int:ELOA | |
| Interaction | ILF3 interactions | CTDSPL2 COBLL1 RPS7 UTP14A NSD1 RBM28 HP1BP3 NIFK IGF2BP1 IGF2BP2 FXR1 BBX BRCA1 CEBPZ DROSHA HSPA9 | 1.36e-04 | 896 | 125 | 16 | int:ILF3 |
| Interaction | E2F4 interactions | HYOU1 TCF20 LIN54 UTP14A ARHGAP11A HP1BP3 NIFK ARID1B FXR1 BRCA1 CEBPZ ENO1 | 1.37e-04 | 540 | 125 | 12 | int:E2F4 |
| Interaction | LHX2 interactions | 1.47e-04 | 183 | 125 | 7 | int:LHX2 | |
| Interaction | SOX2 interactions | HIVEP1 TCF20 LIN54 RPS7 UTP14A NSD1 CHD8 ZDBF2 RBM28 MAST2 BPTF NIFK IGF2BP1 ARID1B IGF2BP2 DDX50 CSNK2A2 RSPO2 HAL ENO1 HSPA9 | 1.70e-04 | 1422 | 125 | 21 | int:SOX2 |
| Interaction | FBL interactions | RPS7 UTP14A NOL10 RBM28 NIFK IGF2BP2 DDX50 BRCA1 CEBPZ RBM19 RPS19BP1 ENO1 PHIP | 1.72e-04 | 639 | 125 | 13 | int:FBL |
| Interaction | SRSF5 interactions | UTP14A NOL10 RBM28 HP1BP3 NIFK PPIG DDX50 CEBPZ RBM19 ZBTB11 RSBN1L | 1.81e-04 | 474 | 125 | 11 | int:SRSF5 |
| Interaction | RPL35 interactions | PLCZ1 CFTR RPS7 NOL10 HP1BP3 NIFK DDX50 BRCA1 CEBPZ RBM19 HADHB ZBTB11 | 1.86e-04 | 558 | 125 | 12 | int:RPL35 |
| Interaction | NOLC1 interactions | 1.96e-04 | 325 | 125 | 9 | int:NOLC1 | |
| Interaction | MKI67 interactions | KIF18A UTP14A CHD8 KIF20B NIFK BBX DDX50 BRCA1 CSNK2A2 ASPM PWWP3A HADHB PLK4 | 1.97e-04 | 648 | 125 | 13 | int:MKI67 |
| Interaction | PRKRA interactions | RBM28 HP1BP3 NIFK IGF2BP1 DDX50 BRCA1 CEBPZ RBM19 ZBTB11 RSBN1L | 1.98e-04 | 400 | 125 | 10 | int:PRKRA |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 6.04e-13 | 149 | 130 | 11 | chr17q12 |
| Cytoband | 17q12 | 9.74e-06 | 99 | 130 | 5 | 17q12 | |
| Cytoband | 12q13.2 | 5.23e-04 | 55 | 130 | 3 | 12q13.2 | |
| Cytoband | 2q24.3 | 9.30e-04 | 16 | 130 | 2 | 2q24.3 | |
| GeneFamily | PWWP domain containing | 8.83e-05 | 22 | 72 | 3 | 1147 | |
| GeneFamily | RNA binding motif containing | 2.04e-04 | 213 | 72 | 6 | 725 | |
| GeneFamily | PHD finger proteins | 4.56e-04 | 90 | 72 | 4 | 88 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 8.13e-04 | 46 | 72 | 3 | 622 | |
| GeneFamily | Heat shock 70kDa proteins | 2.05e-03 | 17 | 72 | 2 | 583 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 2.56e-03 | 19 | 72 | 2 | 832 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 2.84e-03 | 20 | 72 | 2 | 548 | |
| GeneFamily | DNA polymerases | 3.75e-03 | 23 | 72 | 2 | 535 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | KIF18A PRPF38B DZIP1 REV3L ARHGAP11A CDH19 KIF20B CEP350 BPTF USP8 RIF1 PPIG FXR1 BBX BRCA1 CEBPZ ASPM HLTF ZMYM1 ZBTB11 USP1 | 7.31e-12 | 656 | 127 | 21 | M18979 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | KIF18A CTDSPL2 ARHGAP11A KIF20B NIFK RIF1 IGF2BP2 FXR1 CEBPZ SUPT6H ASPM ZBTB11 USP1 ENO1 PLK4 PHIP HSPA9 | 7.81e-08 | 721 | 127 | 17 | M10237 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | KIF18A CENPW CTDSPL2 KIF20B CDKAL1 NIFK RIF1 FXR1 BRCA1 CEBPZ CCNE2 HLTF PHF14 USP1 ENO1 HSPA9 | 9.59e-08 | 644 | 127 | 16 | M10501 |
| Coexpression | FISCHER_DREAM_TARGETS | KIF18A CENPW CTDSPL2 POLE LIN54 ARHGAP11A KIF20B PALB2 CDKAL1 RIF1 BRCA1 ASPM HLTF PKNOX1 TTI1 ZMYM1 USP1 PLK4 HSPA9 | 2.23e-07 | 969 | 127 | 19 | M149 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | KIF18A CENPW CTDSPL2 ARHGAP11A KIF20B SPATA33 RIF1 IGF2BP2 BRCA1 CCNE2 ASPM HLTF PLK4 | 6.04e-07 | 478 | 127 | 13 | M45785 |
| Coexpression | FISCHER_G2_M_CELL_CYCLE | KIF18A ARHGAP11A KIF20B HP1BP3 CEP350 ASPM PKNOX1 ZMYM1 PLK4 | 2.35e-06 | 236 | 127 | 9 | M130 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | KIF18A CTDSPL2 UTP14A ZDBF2 RBM28 ARHGAP11A KIF20B PALB2 NIFK RIF1 FXR1 DDX50 BRCA1 CCNE2 TET1 ASPM TTI1 PHF14 ENO1 PLK4 RSKR | 3.99e-06 | 1407 | 127 | 21 | M14427 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | KIF18A CENPW CTDSPL2 POLE LIN54 ARHGAP11A KIF20B PALB2 RIF1 CCNE2 ASPM USP1 PLK4 | 4.89e-06 | 578 | 127 | 13 | M2368 |
| Coexpression | GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN | 6.16e-06 | 200 | 127 | 8 | M8069 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | KIF18A CENPW CTDSPL2 POLE LIN54 ARHGAP11A KIF20B PALB2 RIF1 CCNE2 ASPM USP1 PLK4 | 6.92e-06 | 597 | 127 | 13 | MM1309 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | KIF18A CENPW CTDSPL2 POLE LIN54 ARHGAP11A KIF20B SPATA33 RIF1 BRCA1 CCNE2 ASPM HLTF USP1 | 7.19e-06 | 694 | 127 | 14 | M45767 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | KIF18A MRPL21 CENPW CTDSPL2 POLE LIN54 NOL10 RBM28 ARHGAP11A KIF20B SPATA33 RIF1 IGF2BP1 BRCA1 CCNE2 ASPM HLTF TTI1 USP1 PLK4 | 8.97e-06 | 1363 | 127 | 20 | M45782 |
| Coexpression | NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | TBC1D3 TBC1D3H UTP14A MAST2 TBC1D3C BBX RBM19 SIGLEC6 TTI1 TBC1D3F | 1.26e-05 | 367 | 127 | 10 | M41159 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | KIF18A CENPW TMEM237 CTDSPL2 POLE LIN54 ARHGAP11A KIF20B RIF1 BRCA1 CCNE2 ASPM HLTF PKNOX1 USP1 PLK4 | 1.28e-05 | 939 | 127 | 16 | M45768 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | HIVEP1 REV3L ARHGAP11A MAST2 KIF20B CEP350 BPTF RIF1 FXR1 BBX BRCA1 HLTF PHF14 ZBTB11 PHIP | 1.77e-05 | 856 | 127 | 15 | M4500 |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | TCF20 POLE RPS7 ARHGAP11A KIF20B RIF1 PPIG BRCA1 CEBPZ CCNE2 TTI1 USP1 PLK4 HSPA9 | 2.01e-05 | 761 | 127 | 14 | M11961 |
| Coexpression | ZHONG_PFC_C1_OPC | 2.18e-05 | 238 | 127 | 8 | M39096 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | KIF18A POLE ARHGAP11A KIF20B BRCA1 FMN1 CCNE2 ASPM USP1 PLK4 | 2.74e-05 | 402 | 127 | 10 | MM454 |
| Coexpression | TRAVAGLINI_LUNG_PROLIFERATING_BASAL_CELL | MRPL21 CENPW TMEM237 KIF21A RPS7 PRPF38B ARHGAP11A KIF20B HP1BP3 PPIG ASPM HADHB USP1 ENO1 HSPA9 | 2.81e-05 | 891 | 127 | 15 | M41654 |
| Coexpression | PGF_UP.V1_UP | 4.04e-05 | 190 | 127 | 7 | M2674 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_UP | 5.42e-05 | 199 | 127 | 7 | M9419 | |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP | 5.59e-05 | 200 | 127 | 7 | M5041 | |
| Coexpression | GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN | 5.59e-05 | 200 | 127 | 7 | M6196 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | TRAPPC11 PRPF38B MAST2 BRCA1 SHPRH CDADC1 PWWP3A DIXDC1 PLCG1 HADHB ENO1 HSPA9 | 7.40e-05 | 646 | 127 | 12 | M2419 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.11e-04 | 300 | 127 | 8 | M8702 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGBP | 1.11e-04 | 300 | 127 | 8 | M39059 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 1.11e-04 | 155 | 127 | 6 | M39041 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | TRAPPC11 PRPF38B MAST2 BRCA1 SHPRH CDADC1 PWWP3A DIXDC1 PLCG1 HADHB ENO1 HSPA9 | 1.12e-04 | 675 | 127 | 12 | MM1073 |
| Coexpression | FAN_EMBRYONIC_CTX_NSC_2 | 1.45e-04 | 233 | 127 | 7 | M39036 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP | 1.47e-04 | 163 | 127 | 6 | M8235 | |
| Coexpression | GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_UP | 1.62e-04 | 166 | 127 | 6 | M9015 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | KIF18A CACNB2 TMEM237 CTDSPL2 KIF20B CDKAL1 NIFK RIF1 IGF2BP1 BRCA1 CCNE2 ASPM HLTF USP1 ENO1 PLK4 HSPA9 | 1.67e-04 | 1290 | 127 | 17 | M80 |
| Coexpression | PUJANA_XPRSS_INT_NETWORK | 1.73e-04 | 168 | 127 | 6 | M18811 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML1 | 2.04e-04 | 328 | 127 | 8 | M39064 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | 2.38e-04 | 426 | 127 | 9 | M9516 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.51e-04 | 180 | 127 | 6 | M8239 | |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_DN | 2.65e-04 | 341 | 127 | 8 | M2879 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_UP | 2.82e-04 | 184 | 127 | 6 | M9988 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_UP | COBLL1 UTP14A CEP350 PPIG FXR1 DDX50 CEBPZ RPS19BP1 HLTF PHF14 USP1 | 3.67e-04 | 658 | 127 | 11 | M40871 |
| Coexpression | YU_BAP1_TARGETS | 3.70e-04 | 29 | 127 | 3 | M2515 | |
| Coexpression | GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN | 3.96e-04 | 196 | 127 | 6 | M7551 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | TCF20 POLE RPS7 ARHGAP11A KIF20B BPTF RIF1 PPIG RGS6 BRCA1 CEBPZ ACOT11 PLCG1 USP1 PLK4 PHIP HSPA9 | 4.11e-04 | 1394 | 127 | 17 | M9585 |
| Coexpression | GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP | 4.17e-04 | 198 | 127 | 6 | M5584 | |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_DN | 4.29e-04 | 199 | 127 | 6 | M9422 | |
| Coexpression | GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_UP | 4.29e-04 | 199 | 127 | 6 | M8035 | |
| Coexpression | GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_DN | 4.29e-04 | 199 | 127 | 6 | M7549 | |
| Coexpression | GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_DN | 4.29e-04 | 199 | 127 | 6 | M8770 | |
| Coexpression | GSE13493_DP_VS_CD8POS_THYMOCYTE_DN | 4.40e-04 | 200 | 127 | 6 | M3315 | |
| Coexpression | GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_UP | 4.40e-04 | 200 | 127 | 6 | M6555 | |
| Coexpression | GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP | 4.40e-04 | 200 | 127 | 6 | M6542 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_UP | 4.40e-04 | 200 | 127 | 6 | M5680 | |
| Coexpression | GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_DN | 4.40e-04 | 200 | 127 | 6 | M6966 | |
| Coexpression | LEE_BMP2_TARGETS_DN | CENPW LIN54 NOL10 NIFK RIF1 BRCA1 ACOT11 CCNE2 RBM19 ZMYM1 USP1 PLK4 HSPA9 | 4.56e-04 | 904 | 127 | 13 | M2325 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 4.58e-04 | 466 | 127 | 9 | M13522 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | KIF18A CACNB2 CENPW CTDSPL2 POLE KIF21A LIN54 NSD1 PRPF38B ZDBF2 REV3L KIF20B PALB2 CDKAL1 CEP350 BPTF RIF1 PPIG IGF2BP1 BRCA1 CCNE2 TET1 ASPM TTI1 PHF14 DIXDC1 MAPK11 USP1 PLK4 PHIP | 3.82e-11 | 1257 | 126 | 30 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | KIF18A CENPW CTDSPL2 POLE LIN54 RPS7 NSD1 PRPF38B ZDBF2 DZIP1 KIF20B PALB2 CDKAL1 IGSF10 RIF1 PPIG FXR1 BRCA1 NRK ASPM PWWP3A TTI1 PHF14 DIXDC1 ZMYM1 USP1 ENO3 PLK4 PHIP | 1.43e-10 | 1241 | 126 | 29 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | KIF18A CACNB2 CENPW CTDSPL2 POLE WNT7A KIF21A LIN54 NSD1 PRPF38B ZDBF2 REV3L KIF20B PALB2 CDKAL1 CEP350 BPTF RIF1 PPIG IGF2BP1 BRCA1 CCNE2 TET1 ASPM TTI1 PHF14 DIXDC1 MAPK11 USP1 PLK4 PHIP | 3.05e-10 | 1459 | 126 | 31 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | KIF18A CENPW CTDSPL2 POLE LIN54 RPS7 NSD1 PRPF38B ZDBF2 DZIP1 GRM4 KIF20B PALB2 CDKAL1 IGSF10 RIF1 PPIG FXR1 BRCA1 NRK ASPM PWWP3A TTI1 PHF14 DIXDC1 ZMYM1 USP1 ENO3 PLK4 PHIP | 1.59e-09 | 1468 | 126 | 30 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 3.22e-09 | 90 | 126 | 9 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | KIF18A POLE KIF21A UTP14A ZDBF2 KIF20B PALB2 RIF1 FXR1 BBX BRCA1 CEBPZ CCNE2 ASPM USP1 PLK4 PHIP | 1.74e-08 | 532 | 126 | 17 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | KIF18A TRAPPC11 CACNB2 TCF20 WNT7A KIF21A LIN54 UTP14A ZDBF2 MAST2 KIF20B RIF1 PPIG BRCA1 CEBPZ CCNE2 ASPM CDADC1 TTI1 PHF14 PHIP | 1.91e-08 | 831 | 126 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | KIF18A UTP14A PRPF38B ZDBF2 KIF20B RIF1 BRCA1 CCNE2 ASPM RSPO2 PHIP | 2.04e-08 | 192 | 126 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | KIF18A CACNB2 CENPW POLE COBLL1 ARHGAP11A KIF20B IGSF10 IGF2BP1 IGF2BP2 BRCA1 CCNE2 TET1 ASPM PLK4 | 3.21e-08 | 422 | 126 | 15 | GSM538355_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | TRAPPC11 CACNB2 TCF20 KIF21A LIN54 FAM161B PRPF38B REV3L MAST2 KIF20B HP1BP3 PPIG DDX50 BRCA1 TET1 CDADC1 TTI1 PHF14 USP1 PHIP | 3.42e-08 | 780 | 126 | 20 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | KIF18A PRPF38B REV3L KIF20B RIF1 PPIG BRCA1 CEBPZ ASPM RSPO2 TTI1 PHF14 PHIP | 4.31e-08 | 311 | 126 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | KIF18A CACNB2 ESS2 ABHD18 ATP8A2 WNT7A KIF21A LIN54 NSD1 PRPF38B ZDBF2 REV3L GRM4 KIF20B BPTF PPIG IGF2BP1 BRCA1 CCNE2 ASPM TTI1 PHF14 MAPK11 ENO3 PLK4 PHIP | 1.07e-07 | 1370 | 126 | 26 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | KIF18A CENPW POLE PRPF38B KIF20B RIF1 FXR1 BBX CEBPZ FMN1 TET1 ASPM TTI1 PLK4 PHIP | 1.27e-07 | 469 | 126 | 15 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | CENPW KIF21A PRPF38B REV3L KIF20B PALB2 PPIG DDX50 BRCA1 RSPO2 TTI1 DIXDC1 USP1 ENO1 PHIP | 2.35e-07 | 492 | 126 | 15 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | CENPW CTDSPL2 PRPF38B REV3L KIF20B RIF1 PPIG DDX50 ACOT11 TET1 RSPO2 TTI1 DIXDC1 ZMYM1 | 2.93e-07 | 432 | 126 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | KIF18A CACNB2 CENPW CTDSPL2 POLE KIF21A LIN54 NSD1 PRPF38B DZIP1 REV3L GRM4 KIF20B IGSF10 RIF1 PPIG TET1 ASPM TTI1 PHF14 DIXDC1 ZMYM1 USP1 PLK4 | 3.01e-07 | 1252 | 126 | 24 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | KIF18A CENPW KIF21A COBLL1 PRPF38B ZDBF2 GRM4 KIF20B PALB2 RIF1 PPIG IGF2BP1 IGF2BP2 BBX BRCA1 CCNE2 DROSHA TET1 TTI1 ZMYM1 MAPK11 USP1 ENO1 ENO3 PHIP | 4.16e-07 | 1371 | 126 | 25 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | KIF18A CENPW UTP14A PRPF38B ZDBF2 H3-4 GRM4 KIF20B PALB2 PPIG IGF2BP1 BRCA1 CEBPZ CCNE2 RBM19 ASPM TTI1 ZMYM1 MAPK11 USP1 ENO1 PLK4 | 1.28e-06 | 1164 | 126 | 22 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | CENPW CTDSPL2 KIF21A PRPF38B REV3L KIF20B RIF1 PPIG BBX DDX50 ACOT11 FMN1 CCNE2 TET1 RSPO2 TTI1 DIXDC1 ZMYM1 ENO1 PHIP | 1.49e-06 | 989 | 126 | 20 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | KIF18A TRAPPC11 CENPW CTDSPL2 WNT7A KIF21A LIN54 PRPF38B ZDBF2 KIF20B RIF1 PPIG IGF2BP1 BRCA1 CCNE2 ASPM PHF14 ZMYM1 USP1 PLK4 | 4.26e-06 | 1060 | 126 | 20 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 5.19e-06 | 213 | 126 | 9 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 5.19e-06 | 213 | 126 | 9 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | KIF18A CTDSPL2 NSD1 REV3L KIF20B CEP350 RIF1 ASPM SHPRH DIXDC1 PHIP | 5.79e-06 | 339 | 126 | 11 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | KIF18A CACNB2 POLE ARHGAP11A KIF20B IGF2BP1 IGF2BP2 BRCA1 CCNE2 TET1 ASPM PLK4 | 7.64e-06 | 419 | 126 | 12 | GSM538348_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | KIF18A WNT7A KIF21A PRPF38B CHD8 ZDBF2 KIF20B CEP350 RIF1 BRCA1 CEBPZ ASPM PHF14 USP1 PHIP | 7.91e-06 | 654 | 126 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | KIF18A WNT7A KIF21A UTP14A PRPF38B ZDBF2 KIF20B RIF1 BRCA1 CCNE2 ASPM RSPO2 PHIP | 8.51e-06 | 498 | 126 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 9.52e-06 | 291 | 126 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.03e-05 | 232 | 126 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | KIF18A CENPW UTP14A PRPF38B ZDBF2 H3-4 GRM4 KIF20B PALB2 PPIG IGF2BP1 BRCA1 CEBPZ CCNE2 RBM19 ASPM TTI1 ZMYM1 MAPK11 USP1 ENO1 PLK4 | 1.33e-05 | 1347 | 126 | 22 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 1.45e-05 | 242 | 126 | 9 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_500 | KIF18A ZCWPW1 CENPW POLE PALB2 RIF1 BRCA1 NRK TET1 HLTF ZMYM1 | 1.95e-05 | 386 | 126 | 11 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.95e-05 | 192 | 126 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B CDRT4 TBC1D3G TBC1D3K TBC1D3F | 2.16e-05 | 320 | 126 | 10 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | KIF18A WNT7A KIF21A UTP14A PRPF38B ZDBF2 REV3L KIF20B RIF1 PPIG BRCA1 CEBPZ CCNE2 ASPM RSPO2 TTI1 PHF14 PHIP | 2.20e-05 | 989 | 126 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | KIF21A PRPF38B KIF20B BPTF RIF1 PPIG BBX CCNE2 SUPT6H TET1 RSPO2 TTI1 ZMYM1 PHIP | 2.26e-05 | 629 | 126 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | KIF18A POLE DZIP1 ARHGAP11A MAST2 KIF20B BRCA1 CCNE2 ASPM USP1 PLK4 | 2.58e-05 | 398 | 126 | 11 | GSM399397_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | TCF20 KIF21A CFTR NSD1 DZIP1 REV3L CEP350 RIF1 IGF2BP1 NRK ASPM SHPRH RSPO2 DIXDC1 GRIN3A PHIP | 2.77e-05 | 818 | 126 | 16 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.81e-05 | 330 | 126 | 10 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | KIF18A TRAPPC11 CENPW CTDSPL2 ATP8A2 WNT7A KIF21A LIN54 PRPF38B ZDBF2 GRM4 KIF20B RIF1 PPIG IGF2BP1 BRCA1 CCNE2 ASPM PHF14 ZMYM1 USP1 PLK4 | 2.81e-05 | 1414 | 126 | 22 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1 | KIF18A POLE ARHGAP11A KIF20B IGF2BP1 IGF2BP2 BRCA1 CCNE2 TET1 ASPM PLK4 | 4.04e-05 | 418 | 126 | 11 | GSM538350_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | KIF18A POLE DZIP1 ARHGAP11A KIF20B BRCA1 CCNE2 TET1 ASPM PLCG1 MAPK11 | 4.40e-05 | 422 | 126 | 11 | GSM476658_500 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | KIF18A POLE ARHGAP11A KIF20B IGF2BP1 IGF2BP2 BRCA1 CCNE2 TET1 ASPM PLK4 | 4.40e-05 | 422 | 126 | 11 | GSM538357_500 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 4.67e-05 | 281 | 126 | 9 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 4.67e-05 | 281 | 126 | 9 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | CENPW KIF21A PRPF38B REV3L KIF20B PALB2 HP1BP3 PPIG DDX50 BRCA1 RSPO2 TTI1 PHF14 DIXDC1 USP1 ENO1 PHIP | 7.33e-05 | 985 | 126 | 17 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.34e-05 | 298 | 126 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.20e-04 | 185 | 126 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | CENPW PRPF38B DZIP1 KIF20B IGSF10 ACOT11 FMN1 NRK RSPO2 TTI1 PHF14 DIXDC1 HADHB GRIN3A USP1 | 1.28e-04 | 834 | 126 | 15 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | PRPF38B DZIP1 REV3L KIF20B IGSF10 PPIG ACOT11 FMN1 NRK RSPO2 PHF14 DIXDC1 HADHB GRIN3A | 1.37e-04 | 744 | 126 | 14 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 1.44e-04 | 255 | 126 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.52e-04 | 328 | 126 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | KIF18A POLE ARHGAP11A KIF20B RIF1 BRCA1 CCNE2 ASPM USP1 PLK4 | 1.95e-04 | 417 | 126 | 10 | GSM399403_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3 | 2.03e-04 | 419 | 126 | 10 | GSM476664_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.19e-04 | 204 | 126 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | KIF18A WNT7A KIF21A PRPF38B CHD8 ZDBF2 KIF20B CEP350 RIF1 BRCA1 CEBPZ NRK ASPM PHF14 USP1 PHIP | 2.36e-04 | 983 | 126 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | KIF18A ZCWPW1 CENPW POLE NOL10 KIF20B PALB2 RIF1 IGF2BP1 BRCA1 NRK TET1 HLTF ZMYM1 | 2.84e-04 | 799 | 126 | 14 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | KIF18A CTDSPL2 COBLL1 NSD1 REV3L KIF20B CEP350 RIF1 ASPM SHPRH HLTF DIXDC1 PLK4 PHIP | 2.91e-04 | 801 | 126 | 14 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.97e-04 | 98 | 126 | 5 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | KIF18A ZCWPW1 POLE KIF21A KIF20B PALB2 RIF1 BBX BRCA1 FMN1 DROSHA TET1 HLTF ZMYM1 | 3.26e-04 | 810 | 126 | 14 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | KIF18A ZCWPW1 CENPW POLE KIF20B PALB2 RIF1 IGF2BP1 BRCA1 DROSHA NRK TET1 HLTF ZMYM1 | 3.78e-04 | 822 | 126 | 14 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 4.08e-04 | 105 | 126 | 5 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_500_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#1_top-relative-expression-ranked_500 | 4.08e-04 | 105 | 126 | 5 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k1_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.11e-04 | 298 | 126 | 8 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#4_top-relative-expression-ranked_500 | 5.98e-04 | 241 | 126 | 7 | gudmap_developingGonad_e12.5_testes_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.13e-04 | 397 | 126 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 | |
| CoexpressionAtlas | B cells, proB.FrBC.FL, CD19+ IgM- CD43+ CD24+ AA4.1+ CD45R+, Fetal Liver, avg-3 | 6.47e-04 | 400 | 126 | 9 | GSM538358_500 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K0 | KIF18A CENPW TMEM237 KIF21A H3-4 GRM4 NIFK RIF1 IGF2BP1 IGF2BP2 BRCA1 CCNE2 ZMYM1 MAPK11 ENO1 PLK4 | 6.63e-04 | 1080 | 126 | 16 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K0 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | CENPW PRPF38B ZDBF2 KIF20B FMN1 RSPO2 TTI1 PHF14 DIXDC1 USP1 | 7.14e-04 | 492 | 126 | 10 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 7.25e-04 | 493 | 126 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | 7.58e-04 | 409 | 126 | 9 | GSM399452_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | KIF18A ZCWPW1 CENPW POLE NOL10 KIF20B PALB2 RIF1 IGF2BP1 BRCA1 TET1 HLTF ZMYM1 | 7.62e-04 | 781 | 126 | 13 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | 7.71e-04 | 410 | 126 | 9 | GSM791122_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 7.71e-04 | 410 | 126 | 9 | GSM538387_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody-blastocyst_vs_EmbryoidBody-fibro_top-relative-expression-ranked_2500_k-means-cluster#1 | KIF18A TRAPPC11 ZFAT ABHD18 PRPF38B CHD8 NOL10 RBM28 RIF1 ARID1B CCDC71 DDX50 TTC21B CDADC1 RBM41 | 8.10e-04 | 993 | 126 | 15 | ratio_EB-blastocyst_vs_EB-fibro_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | 8.18e-04 | 331 | 126 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3 | 8.26e-04 | 414 | 126 | 9 | GSM476660_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 8.61e-04 | 186 | 126 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_500 | 8.90e-04 | 72 | 126 | 4 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k3_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | KIF18A ZCWPW1 POLE KIF20B PALB2 RIF1 BRCA1 CEBPZ DROSHA TET1 HLTF ZMYM1 PLK4 | 8.96e-04 | 795 | 126 | 13 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | 9.02e-04 | 336 | 126 | 8 | GSM538413_500 | |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | 9.60e-04 | 423 | 126 | 9 | GSM791126_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 1.07e-03 | 194 | 126 | 6 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.15e-03 | 349 | 126 | 8 | gudmap_developingGonad_P2_testes_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_100 | 1.22e-03 | 9 | 126 | 2 | gudmap_developingKidney_e15.5_Cap mesenchyme_100_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.23e-03 | 134 | 126 | 5 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.35e-03 | 203 | 126 | 6 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.64e-03 | 369 | 126 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_200 | 1.72e-03 | 40 | 126 | 3 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200_k4 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_OlfPlac_2500_K3 | KIF18A CACNB2 HYOU1 KIF21A COBLL1 ZDBF2 PALB2 RIF1 IGF2BP1 DROSHA RBM19 ZMYM1 MAPK11 USP1 ENO1 PLK4 | 1.78e-03 | 1187 | 126 | 16 | facebase_RNAseq_e9.5_OlfPlac_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.80e-03 | 146 | 126 | 5 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_500 | 1.84e-03 | 376 | 126 | 8 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_500 | |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | 1.96e-03 | 380 | 126 | 8 | GSM538207_500 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.98e-03 | 42 | 126 | 3 | gudmap_developingKidney_e12.5_renal vesicle_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | HIVEP1 CTDSPL2 PRPF38B NOL10 BPTF PPIG SUPT6H RSPO2 TTI1 ZBTB11 | 1.98e-03 | 564 | 126 | 10 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 | KIF18A CENPW TMEM237 KIF21A H3-4 GRM4 NIFK RIF1 IGF2BP1 IGF2BP2 BRCA1 CCNE2 ZMYM1 MAPK11 ENO1 PLK4 | 2.02e-03 | 1202 | 126 | 16 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_500 | 2.20e-03 | 387 | 126 | 8 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_500 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | 2.23e-03 | 388 | 126 | 8 | GSM538352_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | KIF21A ZDBF2 RBM28 H3-4 KIF20B NIFK IGF2BP1 FXR1 CCDC71 CEBPZ MAPK11 ENO1 PLK4 HSPA9 | 2.27e-03 | 991 | 126 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | KIF18A CENPW POLE ARHGAP11A KIF20B HP1BP3 BRCA1 ASPM USP1 PLK4 | 4.03e-10 | 200 | 130 | 10 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.01e-09 | 194 | 130 | 9 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.57e-09 | 196 | 130 | 9 | 0644bd14a944b9c9759a295dfdd5e67a4775f20a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells-Neuroepithelial_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | 7.83e-09 | 200 | 130 | 9 | 2938a029fa0478be561574ace91f95c4a528b2d4 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 7.83e-09 | 200 | 130 | 9 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors_nGenesUnder4k|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.83e-09 | 200 | 130 | 9 | 8223d2c9b9e05b1d26e3de1bc0226d175af2e7b2 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells|3m / Sample Type, Dataset, Time_group, and Cell type. | 7.83e-09 | 200 | 130 | 9 | cfe017b4a4d604a553d0a3df9659687f38e9a7af | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-T/NK_proliferative|URO / Disease, condition lineage and cell class | 7.83e-09 | 200 | 130 | 9 | f277db6cc288a52a5426120c1067608700ee8ccc | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-17|World / Primary Cells by Cluster | 7.83e-09 | 200 | 130 | 9 | 4417f14d45ce683c1a45ec989ae63ee6c047353e | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.83e-09 | 200 | 130 | 9 | 38665128b54f4a81b53c961427aed67bf4e2510b | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.83e-09 | 200 | 130 | 9 | 2154c976f96489d0fa7bfe6ac1cd21edcbefe735 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Stem_cells-Neuroepithelial_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 7.83e-09 | 200 | 130 | 9 | 55501f83409e0174c756a13ad8077f5b59975e27 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Stem_cells|6m / Sample Type, Dataset, Time_group, and Cell type. | 7.83e-09 | 200 | 130 | 9 | b9aad527d3ad5bc701e93fa2afdebf695b2a74bb | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-T/NK_proliferative|Leuk-UTI / Disease, condition lineage and cell class | 7.83e-09 | 200 | 130 | 9 | 093e97395be23092229521cc55aaaee8befbc149 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.37e-08 | 167 | 130 | 8 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.53e-08 | 168 | 130 | 8 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.02e-08 | 180 | 130 | 8 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | URO-Lymphocyte-T_NK-T_NK_proliferative|URO / Disease, Lineage and Cell Type | 7.43e-08 | 185 | 130 | 8 | 0ae9c646679c69a553eda670aef0e0495feb0286 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-T_NK_proliferative|Int-URO / Disease, Lineage and Cell Type | 9.13e-08 | 190 | 130 | 8 | 005967c540418b85311308072a07c684f4296aef | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.13e-08 | 190 | 130 | 8 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 9.51e-08 | 191 | 130 | 8 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 9.51e-08 | 191 | 130 | 8 | a3c5a913a99f17633c140ec9ece81b73e59e0715 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.07e-07 | 194 | 130 | 8 | 7a66bd7d4fc9c6db861cedd2487f241e406869d1 | |
| ToppCell | (1)_T_cells_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.07e-07 | 194 | 130 | 8 | 8f313071933451780309d2174ed27d8cdc734343 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-07 | 195 | 130 | 8 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.11e-07 | 195 | 130 | 8 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.11e-07 | 195 | 130 | 8 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.16e-07 | 196 | 130 | 8 | 6d80e23f6a1725a3f5ea7263233c55c2ea56f977 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-07 | 196 | 130 | 8 | bf1d3fae8c01bb3d17c2dafad92b94937c663acd | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.16e-07 | 196 | 130 | 8 | 3dd7ed1dfac8d90c8a44f0ae00128bb46d9ef496 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-07 | 196 | 130 | 8 | 4f649e3bfd21f21682678828673843a7d51c4ff2 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.16e-07 | 196 | 130 | 8 | 799c290fb3dfacb666dd0dc3c43ec8a86b697ec7 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-07 | 196 | 130 | 8 | 0c003a767c3b58605099dab64b9df0d8e5d8bc4b | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-07 | 196 | 130 | 8 | 5ddd314d3def3776dc7da83778d41c6436ca51ac | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.21e-07 | 197 | 130 | 8 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | Control-Myeloid-proliferating_Myeloid_cells|Control / Disease group,lineage and cell class (2021.01.30) | 1.21e-07 | 197 | 130 | 8 | ddbe3fe078766bb55f0d7ca1aeb8f9e4aa696d8e | |
| ToppCell | severe-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.25e-07 | 198 | 130 | 8 | 4d8591eabb543ed789f963b507a07c560c76a7c9 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.25e-07 | 198 | 130 | 8 | f9f083c76c51b6f014ecf80eaec957eff8d1ab75 | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.25e-07 | 198 | 130 | 8 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.25e-07 | 198 | 130 | 8 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.25e-07 | 198 | 130 | 8 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-T_NK_proliferative|Leuk-UTI / Disease, Lineage and Cell Type | 1.30e-07 | 199 | 130 | 8 | 87113d398585076ece86b9098781e817f8ca241b | |
| ToppCell | (5)_Dendritic_cell-(52)_cycling_DCs|(5)_Dendritic_cell / shred on Cell_type and subtype | 1.30e-07 | 199 | 130 | 8 | d0ff446a197062b10f37b585f3f8716d6d89e5b7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_ventral_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.30e-07 | 199 | 130 | 8 | 446cd7d960812519fe2b8e434578ef0b668c75ce | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_IN_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.30e-07 | 199 | 130 | 8 | f315ec3fb6c0799668c9195f836a77fc0db2b615 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.30e-07 | 199 | 130 | 8 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-Ventral_Precursors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-07 | 200 | 130 | 8 | c8ea0db79b1521f8c90d0d749280c354d3907c3a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-07 | 200 | 130 | 8 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-07 | 200 | 130 | 8 | a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-07 | 200 | 130 | 8 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Stem_cells-Neuroepithelial_cell|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-07 | 200 | 130 | 8 | c865efaaaecccbf9c833d6c1cbe85809a3ec306d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-07 | 200 | 130 | 8 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-07 | 200 | 130 | 8 | 28c702449040ac15fe4e0c6340bb6f137e88539d | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_ventral_progenitors|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-07 | 200 | 130 | 8 | 9359faa749f41aaef70b4874f20b4eed2dc12cc2 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-T/NK_proliferative|Int-URO / Disease, condition lineage and cell class | 1.35e-07 | 200 | 130 | 8 | 99acc1ea01288efdd5b166aa20d66735f2bbe543 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Stem_cells|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-07 | 200 | 130 | 8 | 2ee167b8bddd11fd5b1f61f87fcdf757aee3193e | |
| ToppCell | mild-T/NK_proliferative|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.35e-07 | 200 | 130 | 8 | 25b4a1a33348e274bd4457efc0d6faa5421c3d31 | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.35e-07 | 200 | 130 | 8 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-07 | 200 | 130 | 8 | cea58274efbe7f9e3c3ef9fbb768ebfb917e21d9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Stem_cells|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-07 | 200 | 130 | 8 | 008f137920cc3b599376706803c111d1d0ec17ef | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 1.35e-07 | 200 | 130 | 8 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-07 | 200 | 130 | 8 | 63f9481059be608ddc9fe9c7a8f8503fce9755dd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-07 | 200 | 130 | 8 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Stem_cells-Neuroepithelial_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-07 | 200 | 130 | 8 | 0e119c2742f2be19fde8890d1227bf277ead976f | |
| ToppCell | (3)_MNP-(3)_DC_Monocyte_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.35e-07 | 200 | 130 | 8 | d94fe9bd6ee7c1fed14666f24de41bda014e299b | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-07 | 200 | 130 | 8 | 8f9e76048ae6f45218a09a95a2c4b31e8a8937b2 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-4|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.92e-07 | 166 | 130 | 7 | 52293b8a74d46e6161fb6a2e7e86e51fd9e89a5b | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.16e-07 | 167 | 130 | 7 | bad33497ceeab968a7eb8a48b921c6f936390743 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.67e-07 | 169 | 130 | 7 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.12e-07 | 174 | 130 | 7 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.44e-07 | 175 | 130 | 7 | a154b28b0b2180652d51d4c7d804b3b81b35899e | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.82e-07 | 179 | 130 | 7 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-06 | 180 | 130 | 7 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 181 | 130 | 7 | 3fe648db1cb8326066d8bde3ca1287c5c9af19bd | |
| ToppCell | Healthy_Control-Lymphoid-T-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.06e-06 | 181 | 130 | 7 | ac1ee313910c05b1b3cb497bae14565464919c21 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-06 | 186 | 130 | 7 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-06 | 186 | 130 | 7 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-06 | 187 | 130 | 7 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-06 | 189 | 130 | 7 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.51e-06 | 191 | 130 | 7 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.51e-06 | 191 | 130 | 7 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.51e-06 | 191 | 130 | 7 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.57e-06 | 192 | 130 | 7 | 5ef79faddb433c09ff36660d8bf7a3af5a67bf1d | |
| ToppCell | Dividing_Macrophages-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.57e-06 | 192 | 130 | 7 | 741bd0c2b0a7ce3fcb1610ce8bdacaf9a803c212 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 192 | 130 | 7 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 1.62e-06 | 193 | 130 | 7 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.68e-06 | 194 | 130 | 7 | 22bcfb0f3f73608feb22c0847ab4d34f87aeede0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 194 | 130 | 7 | 1a2090e997c70433d07f56bf7cb0a50c4151118c | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.68e-06 | 194 | 130 | 7 | 5e56ce9b9fe0721be3a9e6efe1422599bb867721 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.68e-06 | 194 | 130 | 7 | 3c385d93c5fe1a7817813c492f79fdb94d887357 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 194 | 130 | 7 | 4c1d13d8cb6fb424655c67755ee6dbaf59d6b418 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.68e-06 | 194 | 130 | 7 | 3a49c7c86036e09a8cd0114988380d04ad1a26fb | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.68e-06 | 194 | 130 | 7 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.74e-06 | 195 | 130 | 7 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.74e-06 | 195 | 130 | 7 | 5790b47b0e028e49b99bda8d6d9e80ac79208cdf | |
| ToppCell | mild-Lymphocytic-Prol._cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.74e-06 | 195 | 130 | 7 | 9a8cc9097a349fd0a53ccf2723ee8bb1418d6aca | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-06 | 195 | 130 | 7 | 043e2f19d95e94cd5219e2c415f322ed340aa80f | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-06 | 196 | 130 | 7 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.80e-06 | 196 | 130 | 7 | 20383d576708b7e4bfce3e9fe40548cce496e3cb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.80e-06 | 196 | 130 | 7 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| Computational | Neighborhood of CCNF | 1.20e-04 | 78 | 67 | 5 | MORF_CCNF | |
| Disease | Intellectual Disability | 1.21e-05 | 447 | 117 | 10 | C3714756 | |
| Disease | Sotos' syndrome | 9.30e-05 | 4 | 117 | 2 | C0175695 | |
| Disease | acquired metabolic disease (implicated_via_orthology) | 9.30e-05 | 4 | 117 | 2 | DOID:0060158 (implicated_via_orthology) | |
| Disease | hereditary breast ovarian cancer syndrome (is_implicated_in) | 1.55e-04 | 5 | 117 | 2 | DOID:5683 (is_implicated_in) | |
| Disease | red blood cell density measurement | ZFAT HIVEP1 WNT7A COBLL1 LIN54 MAST2 KIF20B CDKAL1 ARID1B FMN1 MAML2 USP1 | 2.00e-04 | 880 | 117 | 12 | EFO_0007978 |
| Disease | prostate carcinoma | NSD1 NOL10 MAST2 CDKAL1 CEP350 RIF1 BBX SUGCT FMN1 DIP2C RSPO2 PHIP | 2.25e-04 | 891 | 117 | 12 | EFO_0001663 |
| Disease | eating disorder | 2.77e-04 | 32 | 117 | 3 | EFO_0005203 | |
| Disease | microcephaly (is_implicated_in) | 4.30e-04 | 8 | 117 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | Chronic schizophrenia | 5.51e-04 | 9 | 117 | 2 | C0221765 | |
| Disease | Pancreatic carcinoma, familial | 5.51e-04 | 9 | 117 | 2 | C2931038 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 5.80e-04 | 41 | 117 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 5.80e-04 | 41 | 117 | 3 | C0858252 | |
| Disease | neuroblastoma (is_implicated_in) | 6.87e-04 | 10 | 117 | 2 | DOID:769 (is_implicated_in) | |
| Disease | hematocrit | HIVEP1 CENPW WNT7A COBLL1 LIN54 MAST2 CDKAL1 SPATA33 ARID1B SUGCT FMN1 MAML2 | 6.94e-04 | 1011 | 117 | 12 | EFO_0004348 |
| Disease | acute insulin response measurement | 8.38e-04 | 11 | 117 | 2 | EFO_0006831 | |
| Disease | Male sterility | 9.23e-04 | 48 | 117 | 3 | C0917731 | |
| Disease | Male infertility | 9.23e-04 | 48 | 117 | 3 | C0021364 | |
| Disease | Subfertility, Male | 9.23e-04 | 48 | 117 | 3 | C0848676 | |
| Disease | Liver carcinoma | 9.56e-04 | 507 | 117 | 8 | C2239176 | |
| Disease | sialic acid-binding Ig-like lectin 14 measurement | 1.00e-03 | 12 | 117 | 2 | EFO_0008284 | |
| Disease | anti-Epstein Barr virus antibody measurement | 1.00e-03 | 12 | 117 | 2 | EFO_0009273 | |
| Disease | waist-hip ratio | ZFAT COBLL1 CFTR NSD1 CDKAL1 BPTF IGF2BP2 BBX CSNK2A2 CDADC1 DIXDC1 PHIP RSBN1L | 1.17e-03 | 1226 | 117 | 13 | EFO_0004343 |
| Disease | peak insulin response measurement | 1.18e-03 | 13 | 117 | 2 | EFO_0008000 | |
| Disease | Small cell carcinoma of lung | 1.30e-03 | 54 | 117 | 3 | C0149925 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 1.38e-03 | 14 | 117 | 2 | C0677776 | |
| Disease | cutaneous melanoma | 1.40e-03 | 121 | 117 | 4 | EFO_0000389 | |
| Disease | infant head circumference | 1.58e-03 | 15 | 117 | 2 | EFO_0004577 | |
| Disease | insulin resistance | 1.68e-03 | 59 | 117 | 3 | EFO_0002614 | |
| Disease | body mass index, type 2 diabetes mellitus | 1.80e-03 | 16 | 117 | 2 | EFO_0004340, MONDO_0005148 | |
| Disease | androgenetic alopecia | 1.97e-03 | 133 | 117 | 4 | EFO_0004191 | |
| Disease | body fat percentage, type 2 diabetes mellitus | 2.04e-03 | 17 | 117 | 2 | EFO_0007800, MONDO_0005148 | |
| Disease | Necrotizing Enterocolitis | 2.04e-03 | 17 | 117 | 2 | C0520459 | |
| Disease | Profound Mental Retardation | 2.32e-03 | 139 | 117 | 4 | C0020796 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.32e-03 | 139 | 117 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Mental Retardation, Psychosocial | 2.32e-03 | 139 | 117 | 4 | C0025363 | |
| Disease | Mental deficiency | 2.32e-03 | 139 | 117 | 4 | C0917816 | |
| Disease | diabetes mellitus | 2.52e-03 | 68 | 117 | 3 | EFO_0000400 | |
| Disease | CCL4 measurement | 2.83e-03 | 20 | 117 | 2 | EFO_0004751 | |
| Disease | number of teeth measurement | 2.83e-03 | 20 | 117 | 2 | EFO_0010073 | |
| Disease | Familial aplasia of the vermis | 2.83e-03 | 20 | 117 | 2 | cv:C0431399 | |
| Disease | Adenocarcinoma of prostate | 2.83e-03 | 20 | 117 | 2 | C0007112 | |
| Disease | Bipolar Disorder | 2.98e-03 | 477 | 117 | 7 | C0005586 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.20e-03 | 152 | 117 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | psoriasis, type 2 diabetes mellitus | 3.33e-03 | 75 | 117 | 3 | EFO_0000676, MONDO_0005148 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 3.36e-03 | 364 | 117 | 6 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | body fat percentage | 3.38e-03 | 488 | 117 | 7 | EFO_0007800 | |
| Disease | Primary microcephaly | 3.42e-03 | 22 | 117 | 2 | C0431350 | |
| Disease | risk-taking behaviour | 3.44e-03 | 764 | 117 | 9 | EFO_0008579 | |
| Disease | pulse pressure measurement | CACNB2 ZFAT WNT7A COBLL1 LIN54 GRM4 MAST2 CDKAL1 ARID1B SUGCT SUPT6H TET1 RSKR | 3.54e-03 | 1392 | 117 | 13 | EFO_0005763 |
| Disease | Drugs used in diabetes use measurement | 3.54e-03 | 255 | 117 | 5 | EFO_0009924 | |
| Disease | Alzheimer's disease (is_marker_for) | 3.66e-03 | 257 | 117 | 5 | DOID:10652 (is_marker_for) | |
| Disease | gestational diabetes | 3.73e-03 | 23 | 117 | 2 | EFO_0004593 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VNRNKKSIAVNIKDP | 106 | Q9HAC7 | |
| KQTPRARNQLKRIAK | 1171 | Q7Z4L5 | |
| KNNLVIDTPRVRKQT | 1391 | Q9HCK8 | |
| KRKNSILNPINSIRK | 696 | P13569 | |
| QEPLVGSQKRKARKT | 816 | Q8WY36 | |
| EKPNKQISRVRRKSQ | 91 | Q05D32 | |
| TQKKQERKVRVKSPR | 556 | Q155Q3 | |
| QNVPKRKRSLKAVVT | 851 | Q14833 | |
| RKPKDQVRSSLKNVS | 151 | Q0P651 | |
| SPQEAQIIQAKKRKT | 21 | O96020 | |
| IVSQRKQIKRKAPRG | 6 | Q5EE01 | |
| ARREITKVKLKQITP | 151 | Q8WXI4 | |
| SQPVLKQRRKITSKD | 1686 | Q8NFD5 | |
| DKRQVKRTGLVVVKN | 81 | Q9BWV3 | |
| QAKKRLEQQKPTVIA | 2041 | Q12830 | |
| KPQRKERKKVTAQAI | 841 | Q6DHV5 | |
| QKQRSTIVKNSRRPV | 356 | Q8TF44 | |
| INFKKTQKTIVRVSP | 151 | Q53SF7 | |
| QLRAAPAVQTKTKKT | 31 | P55084 | |
| RTPISKTNKRTKPII | 646 | Q8IZT6 | |
| KTNKRTKPIIAVAQS | 651 | Q8IZT6 | |
| APVKRPRKTKAIQAQ | 31 | Q86WX3 | |
| PRKTKAIQAQKLRNS | 36 | Q86WX3 | |
| KAPLKRSNVEKVTNV | 301 | Q9NTI2 | |
| RQAQAQLEKAKTKPV | 101 | Q08289 | |
| PKVLQRLIKSRGKSQ | 401 | Q08289 | |
| VQKSRKTPQKSRNRK | 231 | Q5SSJ5 | |
| KRITQRKKQEQLTPG | 31 | Q9BYG3 | |
| RATKPAVTLARKKQV | 811 | Q9Y4C8 | |
| AVTLARKKQVPRKQT | 816 | Q9Y4C8 | |
| RKKQVPRKQTTSKIL | 821 | Q9Y4C8 | |
| NIESKVTKPVQIQKR | 256 | Q9NW13 | |
| QIQKRAVKRPAPAKS | 266 | Q9NW13 | |
| KKTKLRATPEAIQNR | 106 | Q96IZ5 | |
| ATNTRVKAKQKPLIS | 691 | Q96L73 | |
| RTILKFPSVQQRKKA | 221 | Q9NZP2 | |
| LAVSRPSKKAKLQRQ | 1241 | Q9H0J4 | |
| QPIRKTTKEDIRKQI | 251 | P49758 | |
| KTTRSNQLVPKKLNI | 821 | Q68DA7 | |
| ITGVKVKRIIKVNNR | 426 | Q6ZRR7 | |
| RQNKPSSVIQPKRRK | 66 | Q8N9R6 | |
| SPVLKQRKKRTFPQI | 401 | Q14667 | |
| LRQKVAVKKLSRPFQ | 46 | Q15759 | |
| TQQLKTVQIAKKPRT | 221 | Q6MZP7 | |
| RLRPVNQNKTVKKNT | 111 | P51114 | |
| EHSVPKKQRSRKIQI | 71 | Q9NZI8 | |
| TNLVKIPTEKRTRRK | 656 | Q8NI77 | |
| VTVKIPKARKRKSNE | 1646 | Q96Q89 | |
| KVVPKVKVLQRDTVR | 136 | Q96LW2 | |
| AEAKISKQKATRRIP | 281 | Q96MY7 | |
| SKQKATRRIPKSILE | 286 | Q96MY7 | |
| APRKQLATKVARKSA | 16 | Q16695 | |
| PRKKVLNAINRRKQV | 391 | Q8N8V4 | |
| VRKEISPAVKKNREQ | 166 | Q07864 | |
| SKKLRSRKIQIRNIP | 76 | Q9Y6M1 | |
| TRAQRVQLKKLPKVN | 436 | Q9BSC4 | |
| KTILKLPSAQQRTKA | 221 | Q8NGE2 | |
| KLINRNTTIPTKKSQ | 456 | P38646 | |
| RRQRQSVLQKKPKAE | 851 | O94880 | |
| KTKRVEKRSNVGPRQ | 996 | Q8TCU5 | |
| RTILKIPSSQQRKKA | 221 | A6NCV1 | |
| IKENQRSPVRVKERK | 391 | Q13427 | |
| QKLPSRRKKQQKRTF | 141 | Q86YC2 | |
| LKRKQVVNLSPANSK | 176 | Q8IZL2 | |
| TVRTLRTKQRIQPQK | 161 | P38398 | |
| LVSVRKNPQTKKIQI | 201 | Q9BRQ4 | |
| TVTNPKRIAKAVNEK | 321 | P06733 | |
| QLFKKPRQVVHKNTR | 236 | Q96DF8 | |
| AKAVRAKAKVARTQP | 346 | Q8IV32 | |
| ITKAQEKTRKRQQPI | 56 | Q9C0G6 | |
| KVVEPKRQKLRAAQA | 2896 | Q9C0G6 | |
| NKESRRKTPVIVTLK | 61 | Q9Y4L1 | |
| PRIRQSNKTNKRIKA | 2141 | Q6WRI0 | |
| IKLTPTAEKRVQKSR | 136 | P42357 | |
| RKDVVPKVRRRNTQK | 31 | Q5VV42 | |
| RNQETIKKSRSPKVL | 201 | Q9BQ39 | |
| VKPVRKVQKVAQLSS | 396 | Q5VT06 | |
| AKIQQLVNTLKRPKR | 256 | Q9Y2E4 | |
| TNNERVVVKILKPVK | 61 | P19784 | |
| FNRTKIASIRKPRKN | 421 | Q6ZMT9 | |
| TEKRTARPVNKVIKS | 1036 | Q6P0Q8 | |
| TKNIVEPPRKRQTKT | 431 | Q96QF7 | |
| RQTKTKNIVEPLRKR | 441 | Q96QF7 | |
| TVTNPKRIAQAVEKK | 321 | P13929 | |
| RKKNPNIKSLVVSQF | 846 | Q14527 | |
| VKQVKRLVPQKQASV | 161 | Q86SE8 | |
| SQTKKVKQPVRSHLR | 26 | Q9H159 | |
| KCVTRLPKETKRQAV | 66 | Q8TEW6 | |
| SQRTSVNKVKNKNRP | 131 | Q03701 | |
| RAPRLLQVQSQVSKK | 486 | Q7Z2Y5 | |
| PAVVKSVRQRDKKAS | 426 | Q2TAK8 | |
| SPFKRKRTTNEIKNL | 536 | Q6PCB5 | |
| KVKSPLKFQRTPVRQ | 826 | Q6P4F7 | |
| ITNDKTKRPVALRTK | 1201 | Q9NRR4 | |
| SLKQVNSARKQLRPK | 121 | Q9BYH1 | |
| KNKQKRPRSRTLTAV | 111 | P62081 | |
| RLVFKIQTQTPRKKT | 306 | Q8N9U0 | |
| KTKKKTAQNRPVQRF | 331 | P55347 | |
| KQQTRVIKKNAFSPR | 521 | Q86YW0 | |
| IRSPKVSNVKKALRI | 2346 | Q5UIP0 | |
| KTRRKKAAQPVQNTD | 371 | O43699 | |
| QAVGSPRKIQKETRK | 526 | Q149N8 | |
| KVQQKRLTKTSRCGP | 306 | B9A6J9 | |
| PIRQKTKKAVVSILD | 601 | O00444 | |
| TRTRQIVKKPVKDTI | 171 | Q6UXX9 | |
| LPSKNRQLIRQKAVS | 636 | Q86YF9 | |
| KPIPRIKRKNNSTTT | 1776 | Q8NFU7 | |
| EAVIQKPRRKTKKTQ | 121 | Q96Q45 | |
| QKSSRKKVVVPQIII | 76 | Q96N06 | |
| QERAKLNITPTKKGR | 611 | Q7KZ85 | |
| KVQQKRLTKTSRCGP | 306 | A6NDS4 | |
| KVQQKRLTKTSRCGP | 306 | P0C7X1 | |
| RKAVPKSAVQQVAQK | 531 | O95625 | |
| NVPSREQEKKRKAQI | 71 | Q9H0M4 | |
| IRKRVKIQTQKTKPR | 476 | Q9H0M4 | |
| KRPRSQKTEKVQKIS | 171 | Q9P243 | |
| RNTKVAVVLIQKKTP | 131 | Q7Z392 | |
| KTCIRSKVANLKNPR | 221 | Q8N8B7 | |
| VPASVKVLRRSNRKK | 1731 | Q8WWQ0 | |
| LANPSIVTKKRNKRN | 1181 | O60673 | |
| KVQQKRLTKTSRCGP | 306 | A6NER0 | |
| EVKPKNKARRRTTTQ | 1146 | Q7Z4S6 | |
| QKNIDQQIKTRPRKI | 226 | Q5VTL8 | |
| VTEPQVAVNKINRKK | 1011 | Q9HCK1 | |
| KKSQRPERKTFQVKL | 41 | P19174 | |
| KVQQKRLTKTSRCGP | 306 | A0A087X179 | |
| QRNPKRITTRHKKQL | 751 | Q9BVJ6 | |
| KKKRIVTTPQTVLRI | 181 | Q7Z2W9 | |
| AQPRKRKTKQAVPIV | 1591 | Q9UGU0 | |
| VRASRNKRPTFLKIK | 241 | O00755 | |
| KVQQKRLTKTSRCGP | 306 | A0A087WVF3 | |
| EKPSLQKRRKIQKSV | 931 | Q5SVZ6 | |
| KVQQKRLTKTSRCGP | 306 | Q6DHY5 | |
| KVQQKRLTKTSRCGP | 306 | Q8IZP1 | |
| KRKPTVTPTVNRENK | 731 | P40818 | |
| RVNEASKQKKPILVR | 1786 | P15822 | |
| SKQKKPILVRQVCTT | 1791 | P15822 | |
| KVQQKRLTKTSRCGP | 306 | A0A087X1G2 | |
| ESPRPSQKKSRVKIN | 326 | O94782 | |
| KVQQKRLTKTSRCGP | 306 | A0A087WXS9 | |
| KVQQKRLTKTSRCGP | 306 | Q6IPX1 | |
| QLKRISKVQAKPAVE | 251 | O43156 |